Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2023 Apr 29:1–26. Online ahead of print. doi: 10.1007/s10586-023-04009-7

Blockchain and COVID-19 pandemic: applications and challenges

Raja Wasim Ahmad 1,2, Khaled Salah 2, Raja Jayaraman 3, Ibrar Yaqoob 2,, Samer Ellahham 4, Mohammed Omar 3
PMCID: PMC10148614  PMID: 37359060

Abstract

The year 2020 has witnessed the emergence of coronavirus (COVID-19) that has rapidly spread and adversely affected the global economy, health, and human lives. The COVID-19 pandemic has exposed the limitations of existing healthcare systems regarding their inadequacy to timely and efficiently handle public health emergencies. A large portion of today’s healthcare systems are centralized and fall short in providing necessary information security and privacy, data immutability, transparency, and traceability features to detect fraud related to COVID-19 vaccination certification, and anti-body testing. Blockchain technology can assist in combating the COVID-19 pandemic by ensuring safe and reliable medical supplies, accurate identification of virus hot spots, and establishing data provenance to verify the genuineness of personal protective equipment. This paper discusses the potential blockchain applications for the COVID-19 pandemic. It presents the high-level design of three blockchain-based systems to enable governments and medical professionals to efficiently handle health emergencies caused by COVID-19. It discusses the important ongoing blockchain-based research projects, use cases, and case studies to demonstrate the adoption of blockchain technology for COVID-19. Finally, it identifies and discusses future research challenges, along with their key causes and guidelines.

Keywords: COVID-19, Blockchain, Healthcare, Traceability, Security

Introduction

Coronavirus disease (COVID-19) is a respiratory infection that has globally affected various sectors such as the economy, healthcare, transportation, and education, to name a few. Health agencies such as the world health organization (WHO) have recommended several protective measures to immediately respond to and limit the unprecedented global spread of COVID-19. The scarcity of medical supplies and hospital capacity has forced government authorities to impose a partial or complete lockdown to contain the spread of the infection. Prevention from the adversarial effects due to the spread of COVID-19 requires coordinated action and collaboration among the health professionals, authorities, research institutes, and government [13]. However, the legacy information management systems being used to store crucial COVID-19-related data are mostly disintegrated [4, 5]. Disintegrated systems suffer from a lack of adequate means to share data and can create information silos for participating organizations. Information silos can minimize collaboration opportunities among participating organizations to combat the COVID-19 pandemic. The use of technologies such as blockchain can assist business organizations in minimizing the adverse effects of the COVID-19 pandemic. The inherent features of blockchain technology can foster information sharing and present a unified view of data to improve the coordination and actions of organizations to minimize the spread of COVID-19.

Numerous technology-based applications have been developed worldwide to assist authorities in closely monitoring public health to combat the COVID-19 pandemic. For example, many corporate sectors, such as Google and Apple, have recently launched contact-tracing applications that can help authorities trace COVID-19-infected persons. Existing solutions, however, require access to personal data such as an individual’s location and COVID-19 test results in order to identify the spread rate and predict viral hotspots within a community [6, 7]. A large portion of the proposed systems have followed a centralized architecture to access, store services, and manage data related to COVID-19. For instance, Singapore’s contact tracing solution, called TraceTogether, employs Bluetooth technology to discover the close contact of a person with an infected patient with COVID-19 [6, 8, 9]. Being a centralized, governed solution, the contact tracing service providers can access user data and compromise data privacy. Similarly, the data records and transactions in centralized-based systems are vulnerable to modifications, fraud, or deletion. Furthermore, centralized systems are less trustworthy due to the possibility of a single point of failure [10, 11]. They can offer limited opportunities for collaboration among organizations, including healthcare, government, and law enforcement agencies [12]. Also, centralized systems fall short of providing traceability, transparency, and immutability of data stored and exchanged during various operational processes to deal with the COVID-19 pandemic [13].

Blockchain is a distributed, decentralized, and immutable record of transactions that are stored on a distributed network of nodes across geographically dispersed locations [3, 14, 15]. The decentralization feature of blockchain technology provides high security and robustness to the data and transactions stored on the blockchain, with no possibility of a single point of failure attack. The record of transactions and data stored on the blockchain is transparent to each member of the network, which builds trust in the reliability and availability of data [3, 16]. Miner nodes in the blockchain network validate the new transactions and add them to the existing blockchain ledger as a new block. Miners are usually rewarded with cryptocurrencies for their mining services. For instance, the proof-of-work (PoW) consensus protocol assures that a miner uses its computational power to solve a cryptographic puzzle for mining a block [1618]. The integrity of transactions on the blockchain network is assured through hashing algorithms and asymmetric cryptography. Blockchain uses asymmetric cryptography to validate the authenticity and integrity of data. Blockchain technology employs hashing (a cryptographic algorithm) to link each block with its predecessor, making the data on the blockchain immutable. In general, blockchain platforms are categorized as permissionless or permissioned blockchain. Any user can join, make transactions, and participate in the mining process on the permissionless blockchain (also known as public blockchain) platform [3, 19]. A permissioned blockchain, on the other hand, is an invitation-only network that is typically managed by a single organization [20]. Access privileges to transact on a permissioned blockchain are limited to members of the organization only [3, 16, 2123]. Hyperledger Fabric and Quorum are permissioned blockchains that allow organizations restricted access to the ledger. Unlike private blockchain platforms, which are managed by a single organization, consortium platforms enable several organizations to control and manage the data on them. Furthermore, consortium and private blockchain platforms offer higher performance and efficiency than public blockchain platforms. Also, the transaction execution time of the consortium and private blockchain platforms is lower than that of the public blockchain platforms. Consortium and private blockchain platforms offer higher data privacy and security compared to public blockchain platforms. The cost of executing a transaction on a public blockchain platform is lower than the cost of executing a transaction on a permissioned blockchain platform [16, 24, 25].

Blockchain technology employs smart contracts to automate business processes and resolve disputes among healthcare collaborators in a reliable and trusted way [26, 27]. A smart contract is a self-executing program that establishes trust among the participating organizations [7, 28, 29]. For instance, in a blockchain-based system used for logistic supply chain management of COVID-19 polymerase chain reaction (PCR) testing kits, smart contracts can play a pivotal role to (a) track the location of shipping containers of testing kits, (b) identify flawed testing kits, (c) monitor the state of testing kits during their shipment, (d) and allow government officials to access data to analyze demand and supply of testing kits in a particular area. Moreover, smart contracts can simplify enrollment, execution, and managerial processes related to vaccine trial tracking, coronavirus disease diagnosis, COVID-19 hotspot identification, COVID-19 outbreak tracking, and user data privacy assurance through the registration services of premissioned blockchain platforms [3034]. Also, smart contracts can assist in identifying, verifying, and preventing the spread of misinformation about COVID-19 [35]. To date, there exist a few surveys that have explored the pivotal role of blockchain technology in combating the COVID-19 pandemic. Unlike the existing surveys, the main contributions of this paper are as follows:

  • It discusses the potential blockchain applications for the COVID-19 pandemic primarily from the public health emergency perspective. Each identified opportunity is further investigated by demonstrating its key role in multiple use-case scenarios.

  • It presents the high-level design of blockchain-based systems for COVID-19 data tracking, digital medical passports, and digital contact tracing to highlight their system-level components, participants, and roles definition.

  • It provides insightful discussions on recent ongoing research projects to show the practicality of blockchain technology in different domains for implementing healthcare services to minimize the spread of COVID-19.

  • It identifies and discusses several key open research challenges that hinder blockchain technology from fully realizing its potential to combat the COVID-19 pandemic.

The methodology of this research consists of the following steps:

  • Step 1: A combination of important keywords such as ’CoV’, ’COVID-19’, and ’Blockchain’ has been used to formulate search queries that follow the formulated research questions. The formulated search queries have been executed on several digital libraries (Web of Science, PubMed, Google, IEEE Xplore, ScienceDirect, and Scopus) to identify and collect the most related studies.

  • Step 2: In the next stage, the collected articles are scrutinized, and duplicate articles are manually removed from the repository by comparing their titles. Subsequently, the remaining articles were re-scrutinized to consider only those that are published in English.

  • Step 3: The next stage further scrutinized the collected articles by selecting only conferences, journals, white papers, magazines, and online web resources to report published data.

  • Step 4: The published articles are reviewed to identify applications, use cases, blockchain-based research projects, case studies, and opportunities for blockchain to combat COVID-19. Through a qualitative research approach, the user requirements, use case participants, and blockchain opportunities for several identified applications are discussed.

  • Step 5: The research challenges that can affect the successful implementation of the identified use cases in combating COVID-19 are discussed.

The remainder of the paper is organized as follows: Sect. 2 explores the potential opportunities offered by blockchain technology to combat the COVID-19 pandemic, illustrates several use cases and applications, and reviews recently reported blockchain-based research projects for combating the COVID-19 pandemic. Section 3 presents a discussion on the research challenges associated with the use of blockchain to combat the COVID-19 pandemic. Section 4 discusses the conclusions and potential opportunities for future research.

Blockchain applications, research projects, and case studies for COVID-19

Blockchain applications for fighting COVID-19

Blockchain technology can assist in building a transparent and efficient healthcare system to combat the COVID-19 pandemic through trusted, verified, distributed, and tamper-resistant ledger technology. It can create the first line of defense through a network of connected devices. In this section, the potential applications and use cases that blockchain technology can provide to deal with the COVID-19 pandemic are discussed. Figure 1 outlines the key services requiring high operational transparency, data provenance, privacy, and security to combat the COVID-19 pandemic.

Fig. 1.

Fig. 1

Leveraging blockchain applications for the COVID-19 pandemic

Track and trace of personal protective equipment

The use of personal protective equipment (PPE) by individuals having exposure to transmittable disease (COVID-19) can greatly prevent and control the spread of the virus. For example, during a COVID-19 health emergency, the use of PPE can reduce the exposure of front-line health professionals to infected people. Examples of PPEs that are primarily used to prevent contact with infected persons or surfaces include gloves, safety goggles, footwear, face masks, helmets, and protective clothing [36, 37]. During the COVID-19 pandemic, many counties have reported a shortage of PPEs in hospitals due to a lack of a trusted system to present accurate data about demand and supply of PPEs. In some cases, due to a limited supply of PPEs and a sudden increase in demand in the health sector, medical professionals were forced to use tape to patch up torn masks in order to avoid contact with COVID-19 [3741]. Several countries and organizations have experienced the supply of low-quality PPEs, including face masks. One of the reasons for the shipment of the low-quality PPE is the limited transparency in the logistics supply chain management process. The existing centralized-based PPE supply chain management systems are inherently incapable of efficiently tracing the data provenance of the PPEs in a trusted and reliable manner. As a result, determining the source of PPEs, as well as additional details such as the type of certification of the PPE, is difficult.

The ability of relevant healthcare organizations to use blockchain to control and manage the supply chain of PPE can greatly aid in detecting PPE-related fraud [39, 42]. It can help in building a more resilient supply chain for PPE [43]. Through blockchain-based systems, the participating organizations can verify the authenticity of PPE and identify any sign of tampering or inadequate handling during its shipment. Blockchain technology securely, immutably, and transparently stores all movements, ownership details, and modifications that are made to the PPE in a distributed ledger. Immutable logs of transactions that are performed by participating organizations support the auditability and provenance of PPE. Blockchain can assist to (a) secure supply chain operations and PPE certificates, (b) prevent compliance violations, (c) identify counterfeit PPEs through data provenance, (d) allow verifiable collateral-based payment settlements, (e) impose penalties on individuals for any failure to comply with safety measures, and (f) procure PPEs from the reputed, trusted, and certified manufacturers. Moreover, smart contracts that are programmed for managing access control and automation can assist governments, authorities, and medical companies to track and trace (in real time) the PPE to forecast demand. PPE traceability-enabled demand forecasting (using AI techniques)can aid in better allocating and reallocating available PPEs [44]. Moreover, through registered and authorized sensors, data can be collected about the available stock in the inventory, and smart contracts can automatically trigger notifications for the procurement managers to place an order for more PPEs to prevent the possible consequences of the PPE shortage [45]. To assure high transparency in the PPE supply chain, public blockchain platforms (Ethereum) should be deployed by the healthcare organizations to track and trace the PPE.

Drug discovery and logistics monitoring of vaccine

To curb the spread of COVID-19, it requires the successful and indispensable immunization of humans against the virus through the administration of an active vaccine. At the time of the writing of this paper, many research institutes and laboratories were in the process of conducting clinical trials of several vaccine candidates. The effectiveness, safety, and genuinity of the vaccine are of great concern to the authorities, governments, and research institutes, as the newly administered vaccine might adversely affect the health of an individual [42, 4648]. The current centralized-based vaccine management systems face several challenges related to the threat of failing to successfully secure and distribute vaccines, and breaching the logistics supply chain of vaccines for malicious purposes. Fake pharmaceutical companies consider this limitation of technology as an opportunity to sell and distribute fake and counterfeit vaccines to cure COVID-19 patients. A fake, counterfeit, or substandard vaccine is mainly manufactured using substandard material [49, 50]. Employing poor manufacturing practices during the development of a vaccine can also result in substandard vaccines. The infiltration of fake, counterfeit, or substandard vaccines into the gray market can harm human lives [51]. For example, because of the lack of operational transparency, adversaries can successfully forge vaccine expiration or production data during manufacturing, processing, shipment, or consumption stages to increase profit [52, 53].

Blockchain technology can permanently store data related to various stages, phases, and events of the COVID-19 vaccine, such as (a) drug discovery, (b) drug development, (c) production, (d) certification, and (e) allotment to authorized organizations for immunization purposes [39]. Drug discovery identifies a compound therapeutically useful in treating COVID-19. Followed by several experimental stages such as synthesis, characterization, and screening of an object, each compound showing encouraging results is selected to develop the COVID-19 vaccine [54]. Blockchain technology can have numerous use cases in assisting the organizations involved in drug discovery [55]. In the drug discovery process, the experimentation equipment generates a massive volume of raw data. Subsequently, this data is processed using statistical tools to create refined data that improves the presentation of the data. Both raw and refined data represent much of the scientific evidence of the experiments performed to discover a drug. Given the scalability issues in existing blockchain platforms, raw and refined data files must be stored on distributed storage systems like IPFS, and hashes of such files must be recorded onto the ledger to provide immutable proof of contents. There could be a threat of hacking or alteration of genomic data by the competing drug discovery organizations. Blockchain can store hashes of timestamped genomic data files onto the ledger to eliminate the chances of data theft, fabrication, and hacking [56]. To protect the data, a system comprised of a public blockchain platform and a trusted network of servers (for proxy re-encryption) can be designed to securely share the hash of a file (containing genomic data) with legitimate users [57]. Furthermore, the designed system can create a collaborative environment by allowing far-located research laboratories to share their research findings (consent-based). Following the drug discovery phase, pre-clinical and clinical trial phases are conducted to assure that the drug is safe for use. Finally, after getting approval from authorities, developed drugs are shipped to hospitals.

In hospitals, medical professionals can access blockchain to identify, trace, and verify vaccine data before administering it. It can also be used for notification management purposes (in real time) through lightweight smart contracts. Smart contracts provide opportunities to detect vaccine-related frauds, assure zero downtime, and eliminate the role of third-party services to monitor COVID-19 vaccine logistics. The immutability feature ensures that the vaccine’s details cannot be changed or deleted by the adversaries. Smart contracts can identify and verify the expiration date of the vaccine in a trusted manner using records such as the manufacturing date and warranty period of the vaccine. Also, smart contracts can use provenance data to identify substandard and falsified vaccines manufactured and shipped by unauthorized manufacturers. For supply chain logistics services, smart contracts implemented on the public blockchain platforms can be configured to monitor the state of the container for temperature, humidity, pressure, and other indices to protect the COVID-19 vaccine during its shipment [43, 58]. The smart contracts can automatically notify the relevant authorities when the pre-assigned conditions for the shipment are violated. The sensors can further assist in identifying any illegal attempts that may disrupt the state of the packages carrying vaccines inside the shipping container. Any such activity can be recorded, audited to monitor non-compliance, and notified in real time to the relevant authority [59]. The other advantages of blockchain for logistics of the future vaccine for COVID-19 include (a) transaction settlement; (b) audit transparency; (c) accurate cost information; (d) automation; (e) reducing human errors; and (f) enforcing tariff and trade policies.

Incentive-based volunteer participation in clinical trials

Conducting clinical trials to develop the COVID-19 vaccine is a complex, time-consuming, and costly process. It requires close coordination and collaboration among organizations that are involved in clinical trials of vaccines, and they are often located at geographically distributed locations. Researchers, donors, and pharmaceutical companies are examples of the organizations that are actively involved in the clinical trials to successfully develop and administer the vaccine for COVID-19. The conventional centralized-based clinical trial data management systems face several challenges, mainly related to subject enrollment, limited performance and non-compliance with the clinical trial requirements, data privacy assurance, compliance with clinical trial rules for the health and safety of participants, and integrity of clinical trial data [7, 6063]. Also, the centralized-based clinical trial management systems can present several versions of clinical trial data that can create information silos within organizations. As a result, it can lead to duplicated clinical trial data that is often stored and managed by multiple organizations. Thus, duplication of clinical trial data makes it difficult to access, process, and analyze results. Also, centralization makes clinical trial data vulnerable to modifications by external hackers or participants. In addition to the data management issues, fair and transparent incentive sharing is challenging for the centralized incentive-based clinical trial management systems. To incentivize participants, centralized incentive-based clinical trial management systems rely primarily on a centralized intermediary service. Incentivizing through intermediary services is both expensive and time-consuming. Also, the existing centralized intermediary services are unable to handle micropayments in a cost-efficient manner.

Blockchain technology can enable pharmaceutical companies and research institutes to preserve the integrity of clinical trial data during the development of a vaccine. It assures that a single and synchronized view of clinical trial data is available for all authorized organizations. Thus, it can successfully overcome issues such as clinical trial data duplication and inconsistency due to the disintegration of the existing centralized-based clinical trial management systems. The smart contracts can verify the access rights of an organization before permitting it to use clinical trial data, preserving data privacy and security. For compliance with clinical trial requirements, smart contracts can verify that the authorized clinical trial participants have digitally signed the consent form [60, 62] before triggering a transaction to read or write health data on the ledger. Therefore, anonymized data collection and verifiable consent management can enable participants to share their case records with the authorized organizations without disclosing their identities. Blockchain enables organizations to use encrypted addresses when transacting on the blockchain to preserve data privacy. Clinical trial activities such as participants’ registration, health data collection, and information sharing should stringently follow the guidelines specified in the clinical trial protocol. The secure tracking and data provenance features allow the food and drug administration (FDA) to confirm that clinical trial activities were carried out in accordance with the protocol guidelines [60, 64]. It is important to note that the study results for many of the vaccine development clinical trials registered at "clinicalTrials.gov" are either unavailable or inconclusive, affecting the health and safety of clinical trial participants [61]. Through the data and operational transparency in clinical trial management, authorized participants can view the current status of the ongoing clinical trials being conducted for COVID-19 vaccine development. Also, the authorities (the FDA) can monitor the trusted health data of the clinical trial participants in a real-time manner. The clinical trial data is analyzed using analytical tools for generating statistical reports to analyze the outcomes of the study. For example, blockchain-based smart contracts can help the FDA identify any serious adverse events (SAEs) caused by the injected vaccine and notify participants in real time [61, 65].

In clinical trial management, patients have the right to accept or reject the proposed changes to the rules specified in the clinical trial consent form. To handle such a problem, a framework named "SCoDES" is developed for consent management in clinical trials to preserve the privacy and confidentiality of users’ data [66]. The SCoDES is being implemented on a hyperledger fabric platform since private platforms (hyperledger fabric) are faster, more secure, and more reliable. Furthermore, private blockchain platforms are suitable for securely storing clinical trial participants’ health data and authorizing the FDA to view it. The private blockchain platform assures that the privacy of participants’ data is preserved by hiding their identities. Thus, suitable use cases for private blockchain platforms in clinical trial management include consent management [67], health data sharing and monitoring in multi-site clinical trials [68], clinical trial results sharing [69], and rewards and incentives for effective coordination, management, and monitoring of clinical trial activities by the authorities. However, the participant’s recruitment for clinical trial management services can be implemented through public blockchain platforms such as Ethereum. To retain the participants of the clinical trial, medicine companies usually offer tokens of appreciation to the participants in the form of cash or gift cards [70]. Smart contracts can assist in speeding up the payment process by providing an automated, transparent, and accountable mode for transferring cryptocurrencies. The transparency and accountability features also assure that the data can be used only for the purpose for which it is collected, increasing the trust of the users.

Delivery of remote healthcare and medical supplies

Using advanced remote health practices such as telehealth and telemedicine services to reduce the risk of contagious virus transmission can allow symptomatic patients to communicate with health specialists remotely via IT infrastructure [71, 72]. Remote diagnosis and treatment of patients can significantly minimize patient access and workforce limitations, and thus the employability of remote health services can effectively control and limit the rapid increase in global COVID-19 cases [2, 73, 74]. Being governed and managed by a centralized authority, remote healthcare systems are vulnerable to a single point of failure problem, which ultimately affects the integrity and trustworthiness of the electronic health records [75]. The inherent features of revolutionary blockchain technology can bring diverse benefits to the remote healthcare industry [30, 7678]. The primary benefits include establishing the provenance of electronic health records [75], verifying the legitimacy of users demanding patient data, ensuring patient anonymity, and automating micropayments for using remote health services [72]. The traceability feature helps successfully establish the provenance of self-testing medical kits for COVID-19 testing. Following the testing outcome, individuals whose test results are negative are usually obliged to follow self-quarantine policies to mitigate the spread of the virus in society. The need for secure track and trace of medical supplies for self-quarantined individuals creates opportunities for blockchain technology to store time-stamped location data of medical supplies on the ledger transparently. To meet the key requirements of patients in terms of health data privacy and security, private or consortium platforms are preferred to implement remote healthcare services.

Maintaining social distance and wearing face masks while performing business activities (relevant healthcare participants) can help to reduce COVID-19 spread.The globally increasing COVID-19 confirmed cases demand contactless delivery of medicines to the patients, especially in areas of very high virus transmission rates, to further prevent COVID-19 from spreading. For this purpose, aerial vehicles can be used to deliver medicines and medical supplies to remote patients. Aerial vehicles can also assist in transporting medical supplies among hospitals that are housed in distant locations. For instance, China experimented (in 2020) with employing aerial vehicles to supply medicines from one city to another during the COVID-19 pandemic [7880]. Blockchain technology can assist in tracking and tracing the location of the aerial vehicles, verifying the provisioned service level, and calculating the reputation score of an aerial vehicle based on its performance in a trusted, accountable, and transparent manner. Through implementing access control protocols and identity management, blockchain technology minimizes the possibility of attacks by adversarial vehicles. It immutably stores commands that are issued to the aerial vehicles (for audit purposes to verify non-compliance with issued commands) by the control room, along with actions to sanitize the highly virus-infected areas and detect human movements and interactions. A swarm is comprised of multiple autonomous aerial vehicles that work together to achieve a common goal. Blockchain technology can be used by a swarm of aerial vehicles to reach a highly reliable global decision by securely transacting on the blockchain. For instance, through a blockchain-based voting system, the aerial vehicles of a swarm can identify the most densely populated public places to spray disinfection [2, 80]. The public blockchain platforms are appropriate for the implementation of the voting service of an aerial vehicle’s swarm to make a decision.

Digital contact tracing

Respecting social distancing directives issued by the government can significantly minimize the social interactions of people to prevent the spread of COVID-19. Social distancing is implemented through a public health measure called "digital contract tracing" that can break the chain of person-to-person transmission of the virus. Digital contact tracing continuously monitors infected people to rapidly and effectively identify all social interactions that happened during the infectious incubation period of COVID-19-infected patients. It mainly employs GPS or Bluetooth to use proximity data to identify social interactions with a virus-infected individual. After encountering close contact with a confirmed COVID-19 case, the exposed individuals are required to be tested, monitored, and self-quarantined [81, 82]. Transparency and immutability of data assure that the health data of users, such as the COVID-19 test result, cannot be altered or deleted by adversaries or healthcare collaborators. Also, it preserves the privacy of users’ data to comply with privacy rules as stated in the General Data Protection Regulation (GDPR) privacy laws [8190]. The design parameters necessary to design and implement a contact tracking solution for identifying social interactions among people are highlighted in Fig. 2. The positioning technique parameter states the technologies that can be used to identify the location of a user. The coverage area parameter defines the range of geographic areas within which a social interaction of a COVID-19 patient with another person can be traced. The heavyweight designs of a contact tracing application intend to use system resources aggressively during identification and verification of social interaction among people. On the other hand, the lightweight application design optimizes system resources by guiding users and providing the most important and needed features. The requirements of digital contact tracing users include an extended battery life of devices and high levels of privacy, security, and transparency of COVID-19-related data. Ideally, a digital contact tracing solution should provide high privacy of data, an extended coverage area, a lightweight application design, high data security and transparency, and battery-friendly operations.

Fig. 2.

Fig. 2

Design parameters for digital contact tracing solutions

The key challenge for digital contact tracing solutions is ensuring the privacy of an individual’s personal health data while minimizing COVID-19 false-positives. The privacy of the data is preserved by encrypting the location and contact history of a person and preventing the disclosure of personal health data to the public [91]. On encountering close contact with a COVID-19-infected patient, users can be informed about the recent social interaction without disclosing the credentials of the infected individual. Bluetooth is used in digital contact tracing via smartphone apps such as TraceTogether in Singapore and Google-Apple contact tracing to identify a person’s close physical contact with a virus-infected individual. However, due to smartphone battery constraints, TraceTogether is not user-friendly [83]. Google/Apple Contact Tracing does not reveal users’ identities or locations, ensuring data privacy. Considering the high privacy and sensitivity of users’ data, the non-blockchain-based solutions are less trustworthy as they are vulnerable to data forging by the administrator of the application [6, 92]. The immutable and decentralized blockchain technology can be a viable alternative for digital contact tracing [93]. It can preserve the privacy of the user’s data by enabling pseudo-anonymity. To preserve data privacy, digital contact tracing using a regular expression matching technique can use the blockchain platform to store social interaction data and allow only authorized users to access the data (via a consent form) [13, 92].

Figure 3 presents a digital contact tracing system that can be used by any organization to ensure safe distancing among its employees to restrain the virus from spreading. In the presented system, an external trusted network of servers is used to generate anonymous addresses for the users to preserve data privacy. The system has implemented many smart contracts, such as entity registration, a geodata processor, COVID-19 testing, query processing, and consent management, to automate services and assure that credentials about individuals who are infected with COVID-19 are not disclosed to others. Being a private blockchain-based system, all entities are registered before making a transaction on the blockchain. The geodata processor contract assures that duplicate data (location data of a user with limited mobility) is not forwarded to the contact solver to speed up the contact tracing process. The COVID-19 testing contract assists in recording COVID-19 test results on the blockchain for each employee. The consent management contract seeks to legalize the location data usage of employees of an organization. The contact solver component of the contact tracing system leverages AI-based techniques for identifying social interactions among individuals [8, 94]. It informs the users about possible risk levels based on many factors, such as distance, mobility, and total time spent during social interaction with a COVID-19-infected person.

Fig. 3.

Fig. 3

Blockchain-based system for digital contact tracing to curb spreading of COVID-19

Vaccination certificates and immunity passports

Antibody testing, also called serology testing, specifies that a person has developed immunity against a virus (COVID-19) after full recovery from the virus. The vaccination certificate enumerates the diseases that a person has been vaccinated against. A vaccination certificate assists in preventing and controlling the spread of COVID-19 by enabling the authorities and governments to formulate policies by allowing cross-border travel for those who possess this certificate [95]. Therefore, the certificate’s forgery protection, high cost-effectiveness, and privacy assurance are the key requirements of the authorities to minimize travel-related frauds. Blockchain-based antibody testing and vaccine certification provide a robust and secure data management system that is easy to administer, unforgeable, and cost-effective [96100]. Blockchain employs asymmetric encryption and decryption schemes [101] and digital signatures to protect antibody testing and vaccine certification data. Also, the decentralization feature assures protection of vaccine certificates against single points of failure or other malicious attacks, thereby increasing the trust of the users by improving data reliability and security. The immunity passport of citizens should be visible to only authorized organizations to preserve users’ data privacy and social and political issues. Therefore, private blockchain platforms are appropriate to implement this service.

The certificate of antibodies can be verified in a trusted way, along with the privacy of the user’s data. For example, when reopening business locations following the COVID-19 pandemic, many organizations can develop and implement policies that allow only employees with a valid digital immunity passport (based on antibody testing and vaccination) to return to work. In such a case, blockchain technology assures that due to the immutability feature, an invalid immunity passport can not be presented to the authorities to access the workplace. The intrinsic transparency and traceability features of blockchain assist in establishing the data provenance of the COVID-19 lab results (through data provided by certification authorities). It can further assist the organizations in verifying the legitimacy of the PCR testing kits that are used for COVID-19 testing. The key organizations or participants that could be involved in the antibody testing and vaccine certification use cases include employees, hospitals, and employers [96, 100, 102]. To conduct antibody testing, hospitals or testing centers (the immunity passport issuer) collect blood or swap samples. It creates a digital passport for the user to immutably record on the ledger. On the other hand, the employer (the immunity passport verifier) can be any organization or authority that verifies that the holder has a valid immunity passport to allow him to visit a building, city, conference, or country.

Figure 4 presents a high-level design of a private blockchain-based system (exemplary system) to create a digital medical passport to maintain the medical identity of citizens and curb the spread of COVID-19 [57]. It has implemented smart contracts to minimize medical-related frauds by presenting test results and medical information to the authorized users in a trusted, reliable, private, and secure manner. It has incorporated self-diverging identity, the interplanetary file system (IPFS), and proxy re-encryption to assist testing centers in providing medical passports and immunity certificates to users. Based on the medical passport, users can be allowed to travel. Upon presentation of a valid digital medical passport, the authorities may exempt an individual from various social restrictions.

Fig. 4.

Fig. 4

High level design of a blockchain-based system for COVID-19 digital medical passports and immunity certificates

Data privacy and self-sovereign identity

Many COVID-19 prevention and control measures, such as strict lockdown, remote health care, and distance-based learning, have recently been implemented globally to minimize social interactions between humans and control the spread of COVID-19 [72]. The government agencies in South Korea had used the personal data of their citizens, including location data and credit card purchase histories, to track the outbreak of COVID-19. The traveling history of citizens, which is identified through their location data, was used to know where the citizens stayed before they were diagnosed positive against the COVID-19 test [3, 103]. Preserving the privacy of citizens’ data along with compliance with the GDPR privacy guidelines can lead to a trusted and dependable system. For many countries, the industry-standard privacy policies state that personally identifiable information should be shared with government agencies to assure the health and safety of citizens, or to fulfill a lawful obligation [104]. Public blockchain-based systems are vulnerable to data privacy breaches as they implement a zero-access control policy to access the blockchain network. However, because they are governed and managed by a single organization, private blockchain platforms are more reliable, trustworthy, and dependable to preserve the privacy of users’ data [104107].

Organizations frequently sign and follow the consent form in order to share citizens’ health data (COVID-19 test result report) with government agencies. A consent form outlines the rules that define the purpose of sharing user data. The blockchain technology can assist the authorities in auditing the operations for any violations or non-compliance while handling or using citizen data in a secure and trustworthy manner. The blockchain-based smart contracts can assure that employees of an organization are immediately notified about their exposure to COVID-19-infected patients. It assures that the credentials of virus-infected individuals are not disclosed to others to preserve data privacy. Identity management self-sovereignty allows users to own and control their identities without the intervention of administrative authorities. It assures that an individual has full control over his data, and he can allow or reject the request by the organizations to share personal health data with them [108111]. Through self-sovereign systems, the data privacy of an individual with symptomatic COVID-19 can be assured, as the user can refuse the request to share personal health data with a health specialist or researcher.

Rapid response registry for medical professionals

Fair allocation and protection of scarce and shareable medical resources in existing public healthcare systems are challenging amid the global COVID-19 pandemic. Many studies have concluded that the COVID-19 pandemic has overwhelmed the world’s existing healthcare system [112]. In such a scenario, rapid and immediate decisions and actions by the authorities or governments in compliance with the agreed-on policies can assure the health and safety of their workers. In health systems, the making of policies for (a) allowing a caregiver to virtually visit quarantine patients, (b) increasing hospital staff and resources, (c) operating AI-based robots to facilitate health professionals to conduct COVID-19 testing, (d) delivering medical supplies through drones, and (e) educating the community to avoid the spreading of false information about COVID-19 can assist in fighting against the COVID-19 pandemic [113, 114]. In traditional healthcare systems, data about medical professionals, such as doctors and nurses, and resources usually sits in the silos of organizations or hospitals. As a result, it creates limited collaboration opportunities among medical professionals enrolled in different hospitals, which are often located at geographically scattered locations, to combat the COVID-19 pandemic [108, 115]. A rapid response registry system registers and maintains a list of medical professionals worldwide along with their roles and expertise to streamline coordination among hospitals or agencies and overcome the scarcity of medical professionals. Public blockchain platforms (along with proxy re-encryption servers [116]) should be considered to implement smart contracts designated for document sharing, payment settlements, physician’s skills verification, and research data sharing [117, 118].

Smart contracts deployed on the blockchain can assist in streamlining the coordinated actions of relevant healthcare organizations to efficiently identify appropriate medical professionals in a highly trustworthy and secure way. Because of a single and unified view of the healthcare data, the authorities can identify the resource capacity, allocation, and demand of a hospital in a seamless, transparent, and trusted manner. A blockchain-based rapid response registry system can allow medical students and health professionals (employed and unemployed) to register on the blockchain platform. A smart contract can continuously monitor the data to assure that it has a large enough pool of reserved medical professionals to provide on-demand services to the hospitals and minimize resource scarcity issues. The on-demand services of unemployed health professionals could be either volunteer or paid (verified through a consent form). After the registration stage, smart contracts can verify the educational certificates that are shared using IPFS servers, the skills that can be traced using blockchain, and other supporting documents to audit fraud. Through transparency and accountability features, it can assure that payments are settled for the services of healthcare professionals in compliance with the rules in the consent form. Similarly, medical professionals who are geographically dispersed can share patient data with COVID-19 via a unified and single blockchain-based health data repository, allowing researchers or health professionals to analyze it. Based on health data analysis, health professionals can learn and apply treatments that are effective for COVID-19 patients. For instance, the analysis of data can be helpful to identify the success rate of patients’ treatments through blood plasma. Details of the effectiveness of the medicines used for the treatment of COVID-19 should be published by the authorized organizations (WHO) on the public blockchain platform.

Tracking of COVID-19 data

In the COVID-19 pandemic, social media has become the most widely acclaimed tool for sharing information. However, due to the open nature of social networks, there is a high probability of misinformation, sensationalism, and rumors about the COVID-19 outbreak. Existing social media channels and websites are incapable to scrutinize and verify the information source [3, 7, 119, 120]. As a result, fabricated or falsified data related to the COVID-19 pandemic, healthcare, or medical devices can cause panic and public confusion about who and which information sources can be trusted. It can lead to harmful self-medication and non-compliance by the public with policies designed by the government related to public movement restrictions and social distancing. Further, any prediction model or estimation of the future growth of COVID-19 using fabricated or falsified data will be meaningless [3, 43, 121]. The trustworthy data about COVID-19 can assist authorities, governments, and agencies to accurately identify infection hotspots within a geographical area and formulate a policy to curb the virus from spreading. Blockchain technology can successfully counter fake information. Using data provenance, it can detect any alteration to data made by adversaries. It assures high reliability, transparency, integrity, and availability of COVID-19 related data for medical professionals and researchers. Thus, tracking trusted COVID-19 data can assist authorities in improving planning and management decisions such as practicing lock-downs to isolate potentially infected territories and outbreak forecasting [3, 7, 121, 122]. To identify the fake news [119], a blockchain-based system can register, rank, and filter news based on the reputation of news agencies.

Figure 5 presents a generic exemplary public blockchain-based system that can be used to track COVID-19-related data, such as the development of medicines for patients with COVID-19, confirmed COVID-19-affected cases, and mortality rate in a particular country, in a highly secure, trusted, and immutable manner [7]. It employed registered oracles to fetch the COVID-19-related data from trustworthy sources such as WHO and the European Center for Disease Control and Prevention (ECDC) websites. It calculates and updates the reputation score of oracles based on their performance behavior. It has implemented three smart contracts called registration, aggregator, and reputation smart contracts. Aggregator’s smart contract provides users with the most recent COVID-19 data. The reputation smart contract either increases or decreases the reputation score of the oracles based on their performance behavior.

Fig. 5.

Fig. 5

Blockchain-based system for COVID-19 related data tracking through oracles and smart contracts

Insurance claims and donations tracking

Health insurance companies can employ trusted blockchain technology to accelerate their growth and market share. The traditional insurance systems face various challenges related to fraudulent claims, complex compliance issues, high convergence times and costs in processing insurance claims, and unverifiable transaction records. In contrast to traditional health insurance systems, blockchain’s accountability, transparency, and verification features can assist insurance companies in conducting audit trials of insurance claims presented by users using an immutable record of health insurance-related transactions [123]. Access to the complete health data about a COVID-19 patient and complying with the terms and conditions that are defined in the consent form can assist the insurers in verifying the patients’ claim in a secure, trusted, and timely fashion. To maintain a healthy lifestyle, insurance companies can give incentives to patients by offering them tokens. Blockchain technology can assist insurance companies in verifying the records of patients to automatically transfer tokens through self-executing smart contracts [124, 125]. The private blockchain platforms are more suitable to implement this use case, as the EHR of a patient should not be disclosed publicly to comply with data protection laws.

Traditional systems that are used for tracking fund donations face many challenges, such as a lack of transparency, trust, accountability, and traceability. Blockchain technology offers a peer-to-peer (P2P) architecture to directly transfer cryptocurrencies to the wallets of the affected people. It assists charitable organizations to verify the cryptocurrency transfers and receipts in a transparent, trusted, and accountable way. It saves time and money by eliminating the role of intermediaries to route the funds to the affected people [126, 127]. The inbuilt transparency, immutability, security, and trust features of blockchain technology can boost fundraising by charitable organizations. The traceability feature can assist the donors in verifying whether their donations are utilized properly. The adaptability of blockchain by charitable organizations can assist government officials in fairly distributing funds among a community’s affected citizens. For instance, because of high levels of traceability, transparency, trust, and security, government officials can verify the funds donated to a community in a particular geographical region. Based on the analysis, it can identify, guide, and direct the donors to a more affected community [2, 7, 126, 127]. Financial transactions (between communities) should be extremely transparent. Hence, a public blockchain platform should be considered to implement this use case.

Aside from the opportunities mentioned above, researchers have begun working to identify CVOID-19-infected individuals through wastewater analysis [128, 129]. Based on wastewater analysis, blockchain technology and AI techniques can assist the authorities in identifying and predicting future hotspots of COVID-19-infected patients in a city. Health professionals can analyze medical images (e.g., cough samples) with the help of AI techniques and data mining models to detect COVID-19 in a community [130, 131]. The rise in blood plasma donations is seen in many developing countries to treat COVID-19 patients [132, 133]. It can be helpful to store the details about plasma donors on the blockchain to verify the effectiveness of COVID-19 treatment through blood plasma donations. However, the privacy of donors’ data should be assured to avoid any criminal activity or political influence that might motivate an individual to donate blood plasma [134].

Summary: A detailed discussion about the potential opportunities of blockchain for the COVID-19 pandemic has been provided to enable government organizations, healthcare professionals, and regulatory authorities to efficiently handle the health emergency caused by the COVID-19 outbreak. It has been discussed how the existing blockchain-based systems help to deal with the COVID-19 pandemic by highlighting their system components, participants, and role definitions for various use cases. It has presented three exemplary blockchain-based systems that can act as a base and a guideline for researchers to propose new blockchain-based systems to implement the remaining seven use cases. The main reason for choosing such reference systems is their usefulness to the government, regularities, and law enforcement agencies in developing and following policies to curb the spread of COVID-19. For instance, the digital contact tracing system (presented in Fig. 3) can be used by government officials to propose and implement smart lockdowns in cities. It can also be used by business organizations and educational institutes to trace the health of their employees. The immunity passport-based system (presented in Fig. 4) can assist the authorities in reopening the businesses by allowing only healthy citizens to visit the business places. The third system, called COVID-19 data tracking (presented in Fig. 5), can be used by citizens and researchers to predict the outbreak of COVID-19 in different regions. It can further help to eliminate the spreading of fakes news about COVID-19. Note that the presented blockchain-based systems can be employed in the other seven use case scenarios as well with minimal efforts and modifications. This study has outlined and presented the system participants, main requirements, and key business processes involved in each use case scenario, which can enable researchers to develop and implement smart contracts using blockchain technology. The participating organizations for all the presented use case scenarios are enlisted in Table 1 to assist researchers in proposing new systems based on existing systems. The main requirements of the participants that should be considered while designing systems for the identified use cases are enumerated in Table 1. Finally, appropriate blockchain platforms are identified based on the needs and requirements of various use case scenarios.

Table 1.

The requirements and opportunities of blockchain technology for several use cases

Application Requirements Blockchain opportunities Participants Remarks
Track and trace of PPE

Fast identification of counterfeit PPE

Availability of provenance data about PPE

High security of PPE related data

Complete trace of PPE manufacturing history

Automation of PPE supply chain operations

Verification of authenticity of PPE

Transparent and fast payment settlements

PPE manufacturer

PPE users

Procurement manager

Distributor

Quality assurance manager

Identifying PPE related frauds require that all participating organizations should be using blockchain technology.

Using high quality and certified PPE can assist in minimizing the spread of COVID-19

Logistics monitoring of vaccine

Verification of genuinity of vaccine

Protection of vaccine related data

Guarantee of vaccine procurement from an authorized manufacturer

Transparency of vaccine logistics operations

Protection of trade documentations

Establishing data provenance of substandard vaccine

Prevention of compliance violation

Vaccine manufacturer

Drug authority

Patients

Shiping agencies

Quality control manager

Distributor

Blockchain-based smart contracts can transparently calculate the reputation score for every vaccine manufacturer.

Blockchain can enable relevant healthcare organizations to locate and buy genuine vaccines from reputed organizations

Incentive-based volunteer participation in clinical trials

The correctness of clinical trials data

Assurance of users data privacy

Assurance of data access and usage in compliance with a consent form

Assurance of compliance with clinical trial rules

Audit of clinical trial operations

Consistency of clinical trial data

Researchers

Regularities

Donors

Drug companies

Blockchain technology can assist in minimizing the efforts required to manage clinical trial documentation
Delivery of remote healthcare and medical supplies

Tracking the location of medical supplies

Tracing the provenance of self-testing COVID-19 test kits

Auditability of air vehicles operations

Access to complete medical history of an individual

Data access and control based on consent management

Patient

Aerial vehicles

Pharmacy

Immutable blockchain technology can help a buyer to view, verify, and validate the health score of a COVID-19 testing kit
Digital contact tracing

Assurance of data privacy

Assurance of data integrity

High accuracy in identifying close contact with infected person

Battery friendly design of application

Seamlessly identify individuals that have come close contact with COVID-19 infected person

Automation of process to notify the exposed individuals

Real-time tracking of location of individuals

Government authorities

Hospitals/COVID-19 testing centers

Individuals & employees

Public/Private institutes & offices

Existing solutions use handheld devices such as smartphone for digital contact tracing.

Digital contact tracing solutions should be battery and CPU resource friendly

Vaccination certificates and immunity passports

Integrity of vaccine certificate

Assurance of data privacy

Trust on COVID-19 antibody testing kits

Identify counterfeit COVID-19 antibody testing kits

Identify invalid immunity passport

Identify valid vaccination certification

Individuals & employee

Hospitals/COVID-19 testing centers

Government

Vaccine manufacturer

Blockchain can assist in assuring compliance with policies to present a valid immunity passport to authorities visit a place/country
Rapid response registry for medical professionals

Registration of medical professionals

Transparent medical resource sharing

Access to skilled medical professionals

Streamline hospital operations

Verify skills of medical professionals

Transparent payment settlement

Verification of educational certificates

Medical professionals

Hospitals staff

Blockchain can assist in availing the services of medical professionals locating geographically at distant locations
Insurance claims

Fast insurance claims settlement

Low cost

Fraudulent claims verification

Verifiability of insurance claims

Monetization of health data

Transparent payment settlement

Insurance company

Patient

Physicians

Blockchain can assist to quickly verify and process insurance claims of COVID-19 patients.

It can assist patients to share their health data with insurers to monetize health data

Donation tracking

Traceability of donation spending

Fast donations processing

Low operational cost

Verifiability of donations spending

Transparency in donation activities

Audit trials of donations

Donors

Government

Communities

Blockchain provides transparency in activities related to funds transferring and consuming that can significantly increase the trust of donors
Data privacy and self-sovereign identity (EHR sharing case)

Complete medical history

Secure data sharing

Consent-based operations

Transparent data sharing

Secure data processing

Enforcement of consent contract

Patient

Primary physician

Secondary physician

Blockchain can assist the primary physician to securely share EHR with the secondary physician to seek his expert opinion (second opinion) on it

Blockchain-based ongoing research projects and case studies for COVID-19

Many organizations have developed blockchain-based systems to offer trust, security, privacy, and operational transparency services in existing healthcare systems. The healthcare services implemented using blockchain-based systems include EHR protection, on-demand remote health monitoring, pharma drug supply chain and clinical trials, a genomic data marketplace, identity management, and health data analytics. Well-known companies such as Burstig, DOC.AI, Mediledger, Guardtime, Chronclid, CallHealth, and Embleema have developed blockchain-based systems to digitize several healthcare services [65]. Ddibloc, MedRec, MedBlock, SMEAD, WellLinc, and MeDShare are examples of blockchain-based systems that have digitized services from the healthcare industry [135137]. This section presents recent ongoing research projects, use cases, and case studies to show how leveraging blockchain technology can help effectively handle a public health emergency caused by the COVID-19 outbreak.

Anonymous COVID-19 testing

Many cases of social discrimination, abuse, and harassment were reported worldwide during the COVID-19 pandemic, in which individuals suffering from COVID-19 symptoms were targeted for causing the pandemic and its spread. To avoid such social discrimination, hospitals or laboratories should preserve the privacy of the COVID-19-infected individuals. Epios is aimed at exploiting the Telos public blockchain platform to facilitate anonymous testing of individuals suffering from COVID-19. The Telos blockchain platform can transparently store and report anonymous test results of individuals and ensures that only authorized users (country managers and regional managers) can write test results on the platform. Telos’ blockchain platform has implemented a delegated proof-of-stake consensus algorithm to verify the transactions. The blockchain platform enables users to connect with laboratories that supply and process PCR testing kits in real time. Epios assures that the payment cannot be made directly to the test processing labs. Instead, it requires the testing kit providers to provide a coupon for each testing kit to users. Further, it cryptographically protects the coupon to assist the labs in verifying the payments without tracing the individual who purchased the PCR testing kit. Teloscoin (Telos) cryptocurrency is available on the Telos blockchain platform, allowing users to pay for used COVID-19 testing services. Also, Epios aims to implement a mobile application that will be used to acquire and submit the testing kits to and from the testers in an anonymous way. The project also aims to share COVID-19-related data with researchers, the government, and authorities, such as an individual’s COVID-19 result and outbreak statistics, while ensuring that an individual’s credentials are not disclosed [138140].

Handling fake infodemic

The COVID-19 outbreak has uncovered the dire need for a reliable, timely, secure, trusted, transparent, and privacy-preserving system that should resolve the issues of existing ad-hoc, siloed, and non-scalable systems for combating the COVID-19 pandemic. The verifiability of COVID-19-related data can profoundly impact decision-making (city lockdown) across several industries worldwide. MiPasa is a multi-source and multi participant-based platform that employs blockchain technology to integrate, process, and share information related to the COVID-19 virus spreading from multiple verifiable sources, such as the WHO and registered health organizations and authorities. It helps authorities or governments identify both human errors and misreporting, thereby enabling data scientists and public health officials to devise solutions to limit the spread of the virus. For instance, employing data analytics on trusted and verified blockchain-based data, MiPasa backed by various analytic tools can assist state organizations in identifying COVID-19 carriers and infection hotspots in a private, secure, and timely manner. It provides the infrastructure that displays the anonymous identities of users who share COVID-19-related data, protecting users’ personally identifiable information (PII). By design, MiPasa is a fully private system that is implemented on top of IBM’s enterprise-grade Hyperledger Fabric platform. Through web-based interfaces, individuals and public health representatives can use MiPasa to upload the location of the infected person. In response, it validates it using data provided by WHO and the ECDC to assure that the new data matches the original. In the next stage, the new verified data is shared with the state authorities and health institutions that are designated by the countries [35, 140143]. MiPasa presents real-time data related to COVID-19, such as new cases, cumulative cases, new deaths, cumulative deaths, and testing samples in different countries. The data presented by MiPasa is mainly taken from diverse sources such as WHO, the University of Oxford, country officials, and the CDC, to name a few.

Global anonymous contact-tracing platforms

Digital contact tracing aims to limit the spreading of airborne infectious viruses such as COVID-19. Leveraging digital contact tracing for identifying infection hotspots through the location of people can affect the user’s privacy. Contact tracing solutions’ and deployment platforms’ technological differences can have an impact on the adaptability and effectiveness of digital contact tracing solutions. The adaptability of contact tracing solutions is also affected by organizational privacy policies and applicable healthcare data regulations. Based on private blockchain technology, VIRI is aimed at filling this research gap by proposing a universal platform on a global scale while preserving users’ data privacy. Developing a cross-entity platform using VIRI to track the spread of the virus in different countries can help identify the COVID-19 outbreak in different places. VIRI’s platform for digital contact tracing ensures user data privacy [144]. It notifies the individuals when they make close contact with an infected person by anonymously tracking a randomly generated user identity. Later on, the individual can be alerted about infectious diseases based on the level of risk. For instance, after crossing paths with infected people, VIRI can change the status of an individual from a "clear case" to a "potentially infected case." Through open APIs, the VIRI platform can be seamlessly integrated with existing enterprise solutions. Thus, enabling the blockchain-based storage of data is anonymous (for privacy preservation), and it can assist machine learning and other AI-based tools to predict the COVID-19 pandemic globally [140, 145, 146].

Data privacy assurance

WIShelter is based on the WiseID application, which is Wisekey’s digital identity platform for providing security services to its users. WiseID is a digital identity solution on the blockchain that can assist organizations in curbing the spread of COVID-19. WIShelter is a smartphone-based application that stores the health data of individuals on the WiseID blockchain in a reliable and trusted manner. The records of the health data include many essential medical specimens, such as allergies, blood pressure, and many other pharmaceutical details. WIShelter aims to facilitate users’ seamless uploading of their digital certificates indicating the results of the COVID-19 test on the blockchain platform [140, 147, 148]. Through WIShelter, the uploaded COVID-19 test results of an individual can be accessed and verified by authorized government officials to issue travel permits to the individual who is willing to travel. However, failing to protect the privacy of users’ data (COVID-19 test results) can result in a variety of problems related to mistreatment and discrimination against infected people. To handle such a situation, WIShelter guarantees that the data of the users cannot be shared with others without their consent. The consent form can be duly signed by the data owner and users, and it could be transparently stored on the blockchain for accountability and audit purposes. Moreover, to secure the medical records and data communication, WIShelter encrypts the user data. Encrypting data also assures the preservation of data privacy, as stated in GDPR. WIShelter can assist authorities in verifying compliance with the stay-at-home policies designed by the authorities for COVID-19-infected patients [147149]. Organizations and healthcare incubator platforms such as VirusIQ have already started using the WIShelter application for secure digital health screening and diagnostic services.

Remote healthcare monitoring systems

Telemedicine is one way to prevent the spread of carnivores through remote patient monitoring. An Ethereum and Hyperledger Fabric-based platform called Medicalchain has been used to implement remote services related to patient-to-doctor consultancy and marketplace applications. Hyperledger Fabric controls access to health records, whereas the ERC20 token on the Ethereum platform assists the health industry to implement services such as patient-to-doctor consulting. It ensures that health data transfers between patients and doctors are secure and private. Through marketplace applications, Medicalchain enables the owner of health data (the patient) to privately share the data with third parties (researchers) based on an agreed-upon consent form [124]. Many healthcare specialists have already registered on the medicalchain platform to offer telehealth services to patients. Another platform called HealPoint enables patients to get a second opinion on their health from a remote doctor. HealPoint is aiming to use the Ethereum platform to implement telehealth services. With the help of Ethereum smart contracts, patients can use the Schelling-coin algorithm (SchCoin) to find the best doctors for them [150]. The Ethereum-based smart contracts can further regulate patients’ and doctors’ interactions, the onboarding process for doctors, and the general consensus of doctors on the health of a patient to reduce the risk of misdiagnosis. Moreover, it can automatically recommend appropriate physicians based on artificial intelligence-based systems using factors such as location, experience, and conflict of interest [151]. Healpoint is in its infant stage, and it aims to use a consortium blockchain platform for health data sharing for research. The Proof of Authority (PoA) protocol will be used by the validators to verify and validate the transactions.

Self-sovereign identity management

The E-Rezept prototype presents a remote healthcare system that is based on the principle of self-sovereign identity (SSI). It enables patients to remotely place an order for medicines by presenting their unique identifiers as proof [140, 152]. To provide telemedicine services to citizens, the E-Rezept used cloud agent infrastructure, smartphone wallets, and an Ethereum blockchain platform. E-Rezept is flexible, and it can be successfully integrated with other SSI solutions such as Hyperledger Indy compared to legacy systems. COVI-ID is a blockchain-based startup that followed a permissioned self-sovereign identity (SSI) network called Sovrin [153] to digitize the contact tracing of people within an organization. The COVI-ID system gives rewards to law-abiding citizens in an accountable and transparent manner [140]. COVI-ID is free and can be used in small businesses such as office parks, restaurants, airports, and retailers. VeChain is a blockchain-based platform that supports real-time monitoring of vaccine development. VeChain is hosted on a public blockchain platform known as VeChainThor. It offers two tokens called vechain token (VET) and vechainthor energy (VTHO). VET is the VeChain token that is used for financial transactions, whereas VTHO represents the total cost of transacting on the blockchain. The vechainthor blockchain platform follows the PoA consensus algorithm for verifying the transactions. It assures that the data related to vaccine development and other details such as materials and codes for packaging are immutable and dependable [140, 154].

COVID-19 data visualization

Hashlog is a blockchain-based system that assisted citizens in tracking, visualizing, and predicting the COVID-19 outbreak. The Hashlog system interacts with the Hedera Hashgraph blockchain platform to provide such data (in real-time) about the COVID-19 outbreak. Hedera Hashgraph is a public blockchain platform that presents a single source of truth about COVID-19 data (Hashlog feature). Hashlog offers open-source web-based APIs that access COVID-19 data released by the WHO and the US center for disease control (USCDC) and store it on the ledger. The Hedera Hashgraph blockchain, on which the Hashlog system has been implemented, can transparently conduct audit trials of the data to verify the accuracy of COVID-19-related data. The coronavirus Hashlog dashboard can assist researchers and scientists to predict COVID-19 confirmed cases, deaths per hundred infections, and virus spreading trends in different regions [140, 155]. RebuildTheChain is another blockchain-based system that is implemented on the blockchain platform and preserves the privacy of the user’s data (geolocation). Citizens’ geolocation data allows the government to issue health cards based on an analysis of their recent visits and interactions with people in various locations. A health card represents the health status of a citizen. RebuildTheChain provides data in real-time about potential COVID-19 cases, virus hotspots, and the status of people under government isolation. The analysis of such records aids government officials in enforcing partial lockdowns to halt the spread of COVID-19. The mobile application interface of the RebuildTheChain system sends warning alerts to citizens when they enter a high-risk zone (a 50-meter geofence) [156].

Open research challenges

This section briefly discusses important open research challenges along with their key causes that hinder the adoption of blockchain for COVID-19 relief. The purpose is to provide guidelines and directions to new researchers aiming to develop immediate blockchain-based solutions to battle COVID-19.

Cross-platforms communication capabilities

The capacity to exchange data, information, and digital assets between different blockchain systems is known as cross-platform communication. Because of the inherent diversity of each platform, it’s likely that the two blockchains will operate under slightly different protocols and administrations. Using a "bridge" formed by an intermediate chain, they are able to exchange data and information securely [157]. Blockchain technology can greatly improve the supply chain of PPE and vaccines by (a) allowing faster and more transparent shipment of COVID-19 prevention materials, (b) enhancing the traceability of shipping materials, and (c) increasing trust among participating organizations by presenting a single and synchronized view of shipment data. It presents a cooperative, accountable, and collaborative environment among the participating organizations, including authorities, the government, hospitals, and research institutes, to fight the COVID-19 pandemic. The blockchain interoperability feature allows disparate blockchain-based systems to uninterruptedly communicate with each other [28, 158]. It enables users to see, share, and access information across several blockchain platforms without requiring intermediary assistance (for translation services). Thus, the blockchain platform’s interoperability support can increase the throughput, safety, and productivity of a system. It also enables a user-friendly experience among multiple users, presents a contactless and easier smart contract execution environment, provides the opportunity to develop partnerships among participating organizations, and allows smooth sharing of information [158160]. For instance, through interoperability-supported blockchain platforms, a user can perform business transactions using Bitcoin tokens on the Ethereum blockchain network. However, the diversity in technologies and differences in software designs of existing blockchain platforms are the major challenges to creating an interoperable blockchain-based system [158, 160]. The disparity in supported languages, data and transaction security in smart contracts, and recommended consensus protocols makes it difficult to propose solutions that support generalized interoperability. Moreover, an interoperable platform that hosts services for organizations that are combating the COVID-19 pandemic should provide high security, fault tolerance, and fast transaction processing.

Smart contracts security audit

Smart contracts implement terms and conditions of agreement among the participating organizations to automate business processes such as tracking and tracing PPE, identifying COVID-19 hotspots through digital contact tracing, verifying vaccination certificates, and issuing immunity passports to individuals willing to travel. They automatically handle the exchange of cryptocurrencies and assets such as PPE, vaccines, and medicines in a manner that is traceable, transparent, and accountable. Despite the many advantages of smart contracts, such as support for automation, ease of debugging, cost efficiency, and limited human intervention required to run business processes, the presence of bugs inside the smart contract code can affect its normal operations and lead to huge losses and disruptions. Being deployed on a decentralized platform, a smart contract can face several security threats from the pseudonymous malicious actors that can fully control the smart contract for malicious purposes [161163]. Smart contracts deployed on public blockchain platforms are often open-source. As a result, publicly accessible data and transactions on the blockchain platform can make the system highly vulnerable to malicious users. The immaturity and lack of understanding of blockchain technology can also result in flaws in the design of smart contracts. The techniques such as ContractLarva, Erays, FSolidM, EtherTrust, KEVM, and Osiris have been proposed to detect bugs and secure smart contracts against attacks of vulnerable entities [162, 164]. Despite several efforts have been made to secure smart contracts, there is still a dire need to propose multi-objective high-performance security protocols to further secure smart contracts.

Data privacy and ethics

Blockchain can significantly overcome traditional clinical trial data management system issues such as data inconsistency and duplication. It stores clinical trial data in a distributed way and enables all miner nodes to possess the entire database. Because of the database’s open nature, organizations have specific concerns about data privacy assurance and security [43, 164, 165]. Data privacy assures that the clinical trial data stored on the blockchain platform should be invisible to unauthorized individuals. It assures that health data is only shared with authorized organizations (government or authorities) and complies with the terms and conditions as defined in the consent form and GDPR privacy laws. Assuring clinical trial data privacy via public blockchain platforms such as Bitcoin and Ethereum is difficult because data and transactions are public; however, private and consortium platforms such as Hyperledger Fabric and Quorum operate in a controlled environment, preserving clinical trial data privacy. Issuing immunity passports to individuals or employees based on vaccination certification is another use case that requires data privacy assurance (from unauthorized users) to effectively eliminate the possibility of any social discrimination with COVID-19-infected patients. Techniques such as zero-knowledge proof, attribute-based encryption (ABE), and multi-party homomorphic obfuscation can protect the privacy of patients’ COVID-19 data [43, 97, 166]. Although the existing medical passport creation schemes have carefully preserved the privacy of COVID-19 data, there exist certain ethical issues that can affect its adaptability [165]. For example, the effect of blockchain on the environment, such as carbon emissions due to huge power consumption poses crucial challenges that must be given adequate attention. [21].

Transaction throughput and network latency

The COVID-19 pandemic necessitates that traditional healthcare systems respond to public health emergencies in a timely and efficient manner. It also requires consistent and close coordination and cooperation among organizations that are involved in health emergency operations to curb the COVID-19 pandemic. Close cooperation and coordination necessitate the maintenance of a consistent and synchronized record of data in order to streamline the operations of participating organizations in order to combat COVID-19. However, the amount of data generated by the organizations is very large. For instance, digital contact tracing requires users to regularly monitor and update their timestamped geodata on the blockchain. Thus, the velocity of data increases, which as a result creates challenges to meet the fast data processing requirements of COVID-19-related affairs (healthcare). The latency of the blockchain network is mainly calculated based on the time required to mine a block. The latency varies depending on the type of blockchain platform used and its specifications [43]. The high latency of a network results in lower transaction throughput. Ethereum, a publicly accessible platform, provides limited transaction privacy and throughput. It has a throughput of twenty transactions per second [167169]. Private blockchain platforms are considered fast and secure and can handle up to several thousand transactions per second [48, 170, 171]. The escalating transaction rate can affect transaction fees, network energy consumption rates, and transaction processing times. The increasing transaction rate also requires blockchain nodes to be more resource-rich to mine large blocks. The incorporation of an additional edge or fog-based layer [172] in the existing frameworks for data pre-processing can help minimize the transaction rate. Besides, communication through off-chain channels and data compression techniques can be handy to handle the escalating rate of transactions.

Slow adoption of blockchain technology

COVID-19 has affected and reshaped the social life, business rules, and well-being of individuals, countries, and communities in various ways. Blockchain technology has sprung up to deal with the affairs that are related to the health of individuals by proposing digital contact tracing solutions. Digital contact tracing ensures compliance with social distancing directives issued by authorities or governments to prevent the spread of the coronavirus. Further, the inherent features of blockchain technology, such as traceability, decentralization, and transparency, can significantly increase trust among organizations that are involved in the manufacturing, certification, and transportation of PPE, vaccines, and medical supplies [38, 47, 169]. Blockchain technology can assist authorities, governments, and medical professionals in reviewing, recording, and tracking of demand, supplies, and logistics of epidemic prevention materials. The digitization of vaccination certification through blockchain to reopen the businesses can greatly minimize the spread of COVID-19 as fake certificates cannot be created and presented (traceability feature) by the employees while returning back to work [48, 96]. Lastly, digitizing commercial transactions through cryptocurrency can not only minimize the time and cost, but also assure seamless authentication of business processes. Despite these advantages of blockchain technology, its adaptability to combat the COVID-19 pandemic is still limited. The main reasons for the slow adoption of blockchain technology are (a) limited incentives for organizations to replace their legacy business practices, (b) lack of laws and regulations for the governance of blockchain technology, and (c) limited understanding and confidence of the users in the evolving blockchain technology. Moreover, a high energy consumption rate and the complexity of mining operations in a blockchain-based system can affect its adaptability [21, 38]. As miners are often spread across various countries and continents, the incompetence of current blockchain technology to clearly define which privacy laws apply to a particular miner node can discourage organizations from adopting blockchain technology. Therefore, further research is required to propose standards, governance rules, and laws for blockchain technology to improve its adaptability by the participating organizations to combat the COVID-19 pandemic.

Concluding remarks and future recommendations

This research has discussed in detail how the emerging blockchain technology’s features and benefits can be leveraged for combating the COVID-19 pandemic. It has explored the potential blockchain applications, mainly from the healthcare emergency perspective, to discuss the key role that blockchain can play during the COVID-19 pandemic. Key requirements of the participating organizations to develop blockchain-based systems for healthcare emergency services to combat the COVID-19 pandemic are identified. Many existing blockchain-based systems that have been developed recently to implement diverse services related to data privacy assurance, remote COVID-19 testing, seamless digital contact tracing, and remote outpatient health monitoring are discussed. Finally, several research challenges that hinder the successful implementation of blockchain technology for healthcare emergency services during the COVID-19 pandemic are identified and presented. The key findings and recommendations based on this research include the following:

  • The advantages of blockchain technology in terms of substantial trust, security, traceability, and transparency can greatly assist the authorities in devising solutions to fight against the COVID-19 pandemic. For instance, immutable data related to the outbreak of COVID-19 in a city can be used by the authorities to correctly identify infection hotspots. Access to such crucial information can assist the authorities in formulating policies for preventing the virus from further spreading.

  • The performance of digital contact tracing solutions greatly depends on the amount and velocity of collected information related to location, travel history, and COVID-19 test results of individuals. It is highly recommended that the privacy of the user’s data be preserved by the contact tracing solutions.

  • Blockchain technology is intended to provide a cooperative, accountable, and collaborative environment for participants that are involved in the supply chain logistics of PPE or vaccines. The adoption rate of blockchain technology by participants greatly depends on operational transparency and assurance of compliance with a regulation to protect data against its misuse.

  • Permissioned blockchain platforms such as Hyperledger Fabric are well suited for digitizing services to develop the COVID-19 vaccine and issue immunity passports to individuals who want to travel. Considering the user requirements of such services, there is a great need to develop lightweight blockchain platforms that should offer better performance.

  • Compliance with GDPR laws for employing blockchain technology to access and use public health and location data by government agencies to make policies for the health and safety of people is challenging. Such limitations can greatly affect the adaptability of blockchain technology.

  • Future research work will explore the role of blockchain technology in the management of hazardous and non-hazardous waste produced during COVID-19 infected patients’ treatment. Blockchain-based systems and architectures will be designed to highlight the key components, participants, and role definitions to trace waste materials such as PPE, swab sticks, and ventilation masks.

Biographies

Raja Wasim Ahmad

received his Ph.D. in computer science from the Center for Mobile Cloud Computing Research (C4MCCR), Faculty of Computer Science and Information Technology (FSKTM), University of Malaya, Malaysia. He completed his masters in computer science from COMSATS University Islamabad (CUI), Abbottabad campus, in 2011. He is currently working as an Assistant Professor at the College of Engineering and IT, Ajman University, United Arab Emirates. He has published several research papers in leading journals and conferences. Most of his research contributions are published in top-cited journals such as IEEE Transactions on Emerging Topics in Computing, IEEE Systems Journal, IEEE Access, Journal of Networks and Computer Applications, Journal of Grid Computing, Cluster Computing, International Journal of Communication Systems, International Journal of Information Management, Journal of Systems and Software, Journal of Supercomputing, IET Intelligent Transport Systems, and Renewable and Sustainable Energy Reviews. Dr. Raja is also serving as a reviewer for several journals and conferences. His research work is well acknowledged in national and international conferences. One of his research articles has received an award of the best paper in SPECTS symposium held in 2018 in France.graphic file with name 10586_2023_4009_Figa_HTML.jpg

Khaled Salah

is a full Professor at the Department of Electrical and Computer Engineering, Khalifa University, UAE. He received the B.S. degree in Computer Engineering with a minor in Computer Science from Iowa State University, USA, in 1990, the M.S. degree in Computer Systems Engineering from Illinois Institute of Technology, USA, in 1994, and the Ph.D. degree in Computer Science from the same institution in 2000. Khaled has over 220 publications and 3 US patents, has been giving a number of international keynote speeches, invited talks, tutorials, and research seminars on the subjects of Blockchain, IoT, Fog and Cloud Computing, and Cybersecurity. Khaled served as the chair of the Track Chair of IEEE Globecom 2018 on Cloud Computing. Khaled is an Associate Editor of IEEE Blockchain Tech Briefs, and a member of IEEE Blockchain Education Commitee. Khaled is now leading a number of projects on how to leverage blockchain for Healthacare, 5G Networks, Combating Deepfake Videos, Supply Chain Management, and AI.graphic file with name 10586_2023_4009_Figb_HTML.jpg

Raja Jayaraman

is an Associate Professor in the Department of Industrial & Systems Engineering at Khalifa University, Abu Dhabi, UAE. He received his Ph.D. in Industrial Engineering from Texas Tech University, a Master of Science degree in Industrial Engineering from New Mexico State University, a Master and Bachelors in Mathematics from India. His expertise is in multi-criteria optimization techniques applied to diverse applications including supply chain and logistics, healthcare, energy, environment and sustainability. Raja’s research interests are primarily focused in using blockchain technology, systems engineering and process optimization techniques to characterize, model and analyze complex systems with applications to supply chains, maintenance operations planning and healthcare delivery. His post doctorial research was centered on technology adoption and implementation of innovative practices in the healthcare supply chains and service delivery. He has led several successful research projects and pilot implementations in the area of supply chain data standards adoption in the US healthcare system. His research has appeared in top rated journals including: Annals of Operations Research, IISE Transactions, Energy Policy, Applied Energy, Knowledge Based Systems, IEEE Access, Journal of Theoretical Biology, Engineering Management Journal and others.graphic file with name 10586_2023_4009_Figc_HTML.jpg

Ibrar Yaqoob

(S'16-M'18-SM'19) is a research scientist at Khalifa University, UAE. Previously, he worked as a research professor at the Department of Computer Science and Engineering, Kyung Hee University, South Korea, where he completed his postdoctoral fellowship. Prior to that, he received his Ph.D. (Computer Science) from the University of Malaya, Malaysia. He has been selected as a highly cited researcher (HCR) worldwide for multiple years, 2021 and 2022, by Clarivate (Web of Science). He is working on the editorial boards of IEEE, Elsevier, and Springer journals. He has been involved in a number of conferences and workshops in various capacities, such as chair and co-chair. His research interests include blockchain, mobile edge/cloud computing, Internet of Things, computer networks, and big data.graphic file with name 10586_2023_4009_Figd_HTML.jpg

Samer Ellahham

(MD, CPHQ, EFQM, FACMQ, FACP, FACC, FAHA, and FCCP) is currently working with Cleveland Clinic Caregiver, Cleveland, US seconded as Senior Cardiovascular Consultant and Director of Accreditation in the Quality and Safety Institute in Cleveland Clinic Abu Dhabi. He is the Middle East regional chair, Patient Safety Movement Foundation, ISQua Expert, AHA Hospital Accreditation Science Committee, Member, European Society of Cardiology Heart Failure Writing Group, Member, ex-Middle East Representative of the JCI Standards Subcommittee and American College of Cardiology Accreditation Foundation Board, Member. Dr. Ellahham received his undergraduate degree in biology and his M.D. from The American University of Beirut, Beirut, Lebanon. Dr. Ellahham finished his internal medicine residency at Georgetown University Hospital - Washington Hospital Center and his fellowship in Cardiology at the Virginia Commonwealth University Health System in the USA. Dr. Ellahham worked in Washington DC at Georgetown University Hospital - Washington Hospital Center and in several clinical and leadership positions before moving to UAE in 2008. He is the Eminent Editor of The Journal of Cardiology & Cardiovascular Therapy and the associate editor of the American Journal of Medical Quality. In addition, he serves on the editorial board of The Journal of Clinical Cardiology and Cardiovascular Research, Developments in Clinical & Medical Pathology (DCMP), the Joint Commission Journal on Quality and Patient Safety, Telehealth and Medicine Today (TMT), Blockchain journal (BHTY), Medical Science, Open Journal of Cardiatic Research, UPI Journal of Pharmaceutical, Medical and Health Sciences (UPI-JPMHS, Open Access Research in Anatomy, Gerontology & Geriatrics studies and Open Access Journal of Clinical Trials, Hypertension Today Journal and Focus on Hypertension Journal, Journal of Heart Health, Cardiovascular Pharmacology, Scientific Research, and Community, Journal of Surgery and Surgical Procedures, EC Cardiology, Journal of Cardiovascular and Pulmonary Medicine, Canadian Journal of Biomedical Research, American Journal of Research in Medical Sciences and International Journal of Open Medicine and Surgery (IJOMASR).graphic file with name 10586_2023_4009_Fige_HTML.jpg

Mohammed Omar

is currently a full Professor and the Founding Chair of the Department of Engineering Systems and Management (currently renamed Industrial and Systems Engineering). Prior to joining the Masdar Institute/KUST, he was an Associate Professor and a Graduate Coordinator with Clemson University, Clemson, SC, USA. He was a part of the Founding Faculty Cohort of Clemson University research park in Greenville, SC, USA. He has over 100 publications in the areas of product lifecycle management, knowledge-based manufacturing, and automated testing systems, in addition to authoring several books and book chapters. He holds four U.S. and international patents. He was named a Tennessee Valley Authority Fellow of two consecutive years during the Ph.D. degree, in addition to being a Toyota Manufacturing Fellow. His professional career includes a Postdoctoral service at the Center for Robotics and Manufacturing Systems CRMS, and a Visiting Scholar at the Toyota Instrumentation and Engineering Division, Toyota Motor Company, Japan. His group graduated seven Ph.D. dissertations and over 35 M.Sc. theses. Four Ph.D. students are currently on academic ranks in U.S. universities. His work has been recognized by the U.S. Society of manufacturing engineers SME through the Richard L. Kegg Award. He has also received the SAE Foundation Award for Manufacturing Leadership. In addition, he has received the Murray Stokely Award from the College of Engineering, Clemson University. He has also led an NSF I/UCRC Center and a part of the DoE GATE Center of Excellence in Sustainable Mobility Systems. His current research interests include capabilities in composite fabrication and manufacturing analytics at a laboratory Masdar City Campus. His current research group supported two Postdoctoral Scholar’s Career Planning to become an Assistant Professor at the Texas A&M (TAMUQ), in 2013, and the University of Sharjah, in 2015. He currently serves as an Editor-in-Chief for the Journal of Material Science Research (Part of the Canadian Research Center), and as an Associate Editor for the Journal of Soft Computing (a Springer), handling the areas of decision science, knowledge-based systems, in addition to his membership on several editorial boards and conference organizations. Furthermore, he serves on the Advisory Board of the Strata PJSC (part of Mubadala Aerospace).graphic file with name 10586_2023_4009_Figf_HTML.jpg

Author contributions

All authors contributed to the study conception, investigation, validation, and writing—review editing. All authors read andapproved the final manuscript.

Funding

This publication is based upon work supported by the Khalifa University of Science and Technology under Awards No.CIRA-2019-001 and RCII-2019-002, Center for Digital Supply Chain and Operations Management.

Data availability

Not applicable.

Declarations

Conflict of interest

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethical approval

Ethics approval was not required for the conduct of this research.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Pham QV, Nguyen DC, Hwang WJ, Pathirana PN, et al. Artificial intelligence (AI) and big data for coronavirus (COVID-19) pandemic: a survey on the state-of-the-arts. IEEE Access. 2020;8:130820–130839. doi: 10.1109/ACCESS.2020.3009328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Chamola V, Hassija V, Gupta V, Guizani M. A comprehensive review of the COVID-19 pandemic and the role of IoT, Drones, AI, Blockchain, and 5G in managing its impact. IEEE Access. 2020;8:90225–90265. doi: 10.1109/ACCESS.2020.2992341. [DOI] [Google Scholar]
  • 3.Nguyen D, Ding M, Pathirana PN, Seneviratne A. Blockchain and AI-based solutions to combat coronavirus (COVID-19)-like epidemics: a survey. TechRxiv. 2020 doi: 10.20944/preprints202004.0325.v1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Roman-Belmonte JM, De la Corte-Rodriguez H, Rodriguez-Merchan EC. Blockchain in Healthcare: From Disruption to Integration. Springer; 2023. Applications of blockchain technology in the covid-19 era; pp. 53–67. [Google Scholar]
  • 5.Zhang Z, Tao B, Li X, Dai HN. Blockchain in Healthcare: From Disruption to Integration. Springer; 2023. An amalgamation of blockchain and connected health for combating covid-19; pp. 37–52. [Google Scholar]
  • 6.Ahmed, N., Michelin, R. A., Xue, W., Ruj, S., Malaney, Kanhere, S. S., Seneviratne, A., Hu, W.,  Janicke, H., Jha, S.: A survey of COVID-19 contact tracing Apps. Preprint at https://arvix.org/abs/2006.10306 (2020)
  • 7.Marbouh D, Abbasi T, Maasmi F, Omar I, Debe M, Salah K, Jayaraman R, Ellahham S. Blockchain for COVID-19: review, opportunites and a trusted tracking system. TechRxiv. 2020 doi: 10.36227/techrxiv.12609344.v2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Xu, H., Zhang, L., Onireti, O., Fang, Y., Buchanan, W. B., Imran, M. A.: Beeptrace: blockchain-enabled privacy-preserving contact tracing for COVID-19 pandemic and beyond. Preprint at https://arvix.org/abs/2005.10103 (2020) [DOI] [PMC free article] [PubMed]
  • 9.Bay J, Kek J, Tan A, Hau CS, Yongquan L, Tan J, Quy TA. Bluetrace: a privacy-preserving protocol for community-driven contact tracing across borders, Government Technology Agency-Singapore. Tech. Rep. 2020;18:1. [Google Scholar]
  • 10.Fitzgerald MH, Phillips PA. Centralized and non-centralized ethics review: A five nation study. Account. Res. 2006;13(1):47–74. doi: 10.1080/08989620600588944. [DOI] [PubMed] [Google Scholar]
  • 11.Kungpisdan S. 9th International Symposium on Communications and Information Technology. IEEE; 2009. Accountability in centralized payment environments; pp. 1022–1027. [Google Scholar]
  • 12.Balasubramanian S, Shukla V, Sethi JS, Islam N, Saloum R. A readiness assessment framework for blockchain adoption: a healthcare case study. Technol Forecast Soc Change. 2021;165:120536. doi: 10.1016/j.techfore.2020.120536. [DOI] [Google Scholar]
  • 13.Liu M, Zhang Z, Chai W, Wang B. Privacy-preserving covid-19 contact tracing solution based on blockchain. Comput Stand Interf. 2023;83:103643. doi: 10.1016/j.csi.2022.103643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ahmad RW, Salah K, Jayaraman R, Yaqoob I, Omar M, Ellahham S. Blockchain-based forward supply chain and waste management for covid-19 medical equipment and supplies. IEEE Access. 2021;9:44905–44927. doi: 10.1109/ACCESS.2021.3066503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Chen Y, Chen S, Liang J, Feagan LW, Han W, Huang S, Wang XS. Decentralized data access control over consortium blockchains. Info Syst. 2020;94:101590. doi: 10.1016/j.is.2020.101590. [DOI] [Google Scholar]
  • 16.Yeow K, Gani A, Ahmad RW, Rodrigues JJ, Ko K. Decentralized consensus for edge-centric internet of things: A review, taxonomy, and research issues. IEEE Access. 2017;6:1513–1524. doi: 10.1109/ACCESS.2017.2779263. [DOI] [Google Scholar]
  • 17.Xu J, Wang C, Jia X. A survey of blockchain consensus protocols. ACM Computing Surveys; 2023. [Google Scholar]
  • 18.Kaur A, Nayyar A, Singh P. Blockchain: A path to the future. Cryptocurrencies Blockchain Technol Appl. 2020;2020:25–42. doi: 10.1002/9781119621201.ch2. [DOI] [Google Scholar]
  • 19.Vujičić D, Jagodić D, Ranić S. International Symposium Infoteh-jahorina (Infoteh) IEEE; 2018. Blockchain technology, Bitcoin, and Ethereum: a brief overview; pp. 1–6. [Google Scholar]
  • 20.Oikonomou FP, Ribeiro J, Mantas G, Bastos JMC, Rodriguez J. IEEE International Mediterranean Conference on Communications and Networking (MeditCom) IEEE; 2021. A hyperledger fabric-based blockchain architecture to secure iot-based health monitoring systems; pp. 186–190. [Google Scholar]
  • 21.Denisova V, Mikhaylov A, Lopatin E. Blockchain infrastructure and growth of global power consumption. International Journal of Energy Economics and Policy. 2019;9(4):22. doi: 10.32479/ijeep.7685. [DOI] [Google Scholar]
  • 22.Bach, L., Mihaljevic, B., Zagar, M.: Comparative analysis of blockchain consensus algorithms. In: 41st International Convention on Information and Communication Technology, Electronics and Microelectronics (MIPRO). pp. 1545–1550. IEEE, (2018)
  • 23.Radanović I, Likić R. Opportunities for use of blockchain technology in medicine. Applied health economics and health policy. 2018;16(5):583–590. doi: 10.1007/s40258-018-0412-8. [DOI] [PubMed] [Google Scholar]
  • 24.Alsamhi S., Lee, B.: Blockchain for multi-robot collaboration to combat covid-19 and future pandemics. Preprint at http://arxiv.org/abs/2010.02137, (2020) [DOI] [PMC free article] [PubMed]
  • 25.Zhen, Y., Yue, M., Zhong-Yu, C., Chang-bing, T., Xin, C.: Zero-determinant strategy for the algorithm optimize of blockchain PoW consensus. In: 36th Chinese Control Conference (CCC), pp. 1441–1446. IEEE, (2017)
  • 26.Villarreal, E. D., García-Alonso, J., Moguel, E., Alegría, J. A. H.: Blockchain for healthcare management systems: a survey on interoperability and security. IEEE Access (2023)
  • 27.Yaqoob, I., Salah, K., Jayaraman, R., Al-Hammadi, Y.: Blockchain for healthcare data management: opportunities, challenges, and future recommendations. Neural Comput Appl 2021, 1–16 (2021)
  • 28.De Carlo R. W. M.: Blockchain and interoperability: key to mass adoption [Online]. https://www.finextra.com/blogposting/18972/blockchain-and-interoperability-key-to-mass-adoption (2020). Accessed on 12 Aug 2020
  • 29.Nassar, M., Salah, K., ur Rehman, H., Svetinovic, D.: Blockchain for explainable and trustworthy artificial intelligence. Wiley Interdiscip. Rev. Data Mining Knowl. Discov. 10(1), e1340 (2020)
  • 30.Azim, A., Islam, M.N., Spranger, P.E.: Blockchain and novel coronavirus: towards preventing COVID-19 and future pandemics. Am. J. Med. (2020)
  • 31.Tan L, Yu K, Shi N, Yang C, Wei W, Lu H. Towards secure and privacy-preserving data sharing for covid-19 medical records: a blockchain-empowered approach. IEEE Transactions on Network Science and Engineering. 2021;9(1):271–281. doi: 10.1109/TNSE.2021.3101842. [DOI] [Google Scholar]
  • 32.Ricci, L., Maesa, D.D.F., Favenza, A., Ferro, E.: Blockchains for covid-19 contact tracing and vaccine support: a systematic review. IEEE Access 9, 37936–37950 (2021) [DOI] [PMC free article] [PubMed]
  • 33.Kamenivskyy Y, Palisetti A, Hamze L, Saberi S. A blockchain-based solution for covid-19 vaccine distribution. IEEE Engineering Management Review. 2022;50(1):43–53. doi: 10.1109/EMR.2022.3145656. [DOI] [Google Scholar]
  • 34.Alansari SA, Badr MM, Mahmoud MM, Alasmary W, Alsolami F, Ali AM. Efficient and privacy-preserving infection control system for covid-19-like pandemics using blockchain. IEEE Internet of Things Journal. 2021;9(4):2744–2760. doi: 10.1109/JIOT.2021.3092601. [DOI] [Google Scholar]
  • 35.Susan M.: Building a blockchain to verify COVID-19 data [Online]. https://gcn.com/articles/2020/04/06/mipasa-blockchain-covid-tracking.aspx (2020). Accessed on 03/08/2020
  • 36.Livingston E, Desai A, Berkwits M. Sourcing personal protective equipment during the COVID-19 pandemic. Jama. 2020;323(19):1912–1914. doi: 10.1001/jama.2020.5317. [DOI] [PubMed] [Google Scholar]
  • 37.Bauchner H, Fontanarosa PB, Livingston EH. Conserving supply of personal protective equipment. Europe PMC. 2020;323(19):1911–1911. doi: 10.1001/jama.2020.4770. [DOI] [PubMed] [Google Scholar]
  • 38.Nagesh S., Chakraborty, S.: Saving the frontline health workforce amidst the COVID-19 crisis: challenges and recommendations. J. Global Health 10, 1 (2020) [DOI] [PMC free article] [PubMed]
  • 39.Rowan N.J., Laffey, J.G.: Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from coronavirus disease (COVID19) pandemic–case study from the republic of ireland. Sci. Total Environ. 40, 138532 (2020) [DOI] [PMC free article] [PubMed]
  • 40.Girardi F, De Gennaro G, Colizzi L, Convertini N. Improving the healthcare effectiveness: The possible role of EHR, IoMT and Blockchain. Electronics. 2020;9(6):884. doi: 10.3390/electronics9060884. [DOI] [Google Scholar]
  • 41.Kang, L., Li, Y., Hu, S., Chen, M., Yang, C., Yang, B.X., Wang, Y., Hu, J., Lai, J., Ma, X., et al.: The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry 7(3), e14 (2020) [DOI] [PMC free article] [PubMed]
  • 42.Clauson KA, Breeden EA, Davidson C, Mackey TK. Leveraging blockchain technology to enhance supply chain management in healthcare: An exploration of challenges and opportunities in the health supply chain. Blockchain in Healthcare Today. 2018;1(3):1–12. [Google Scholar]
  • 43.Kalla, A., Hewa, T., Mishra, R.A, Ylianttila, M.,  Liyanage, M.: The role of blockchain to fight against COVID-19. IEEE Eng. Manag. Rev. 10, 20 (2020)
  • 44.Kevin B.: Unlocking the power of predictive analytics with AI. (2021)
  • 45.Omar, I.A., Debe, M., Jayaraman, R., Salah, K., Omar, M., Arshad, J.: Blockchain-based supply chain traceability for covid-19 personal protective equipment. Comput. Ind. Eng. 167, 107995 (2022) [DOI] [PMC free article] [PubMed]
  • 46.Yong, B., Shen, J., Liu, X., Li, F., Chen, H., Zhou, Q.: A blockchain based system for safe vaccine supply and supervision. Preprint at http://arxiv.org/abs/2004.06081
  • 47.Ramirez Lopez, L.J., Beltrán Álvarez, N.: Blockchain application in the distribution chain of the COVID-19 vaccine: a designing under study. (2020)
  • 48.Yong, B., Shen, J., Liu, X., Li, F., Chen, H., Zhou, Q.: An intelligent blockchain-based system for safe vaccine supply and supervision. Int. J. Info. Manag. 52, 102024 (2020)
  • 49.Fu C. Milestone and challenges: Lessons from defective vaccine incidents in China. Human Vaccines & Immunotherapeutics. 2020;16(1):80–80. doi: 10.1080/21645515.2019.1646579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Peysson LF. Tracing and control of raw materials sourcing for vaccine manufacturers. Biologicals. 2019;38(3):352–353. doi: 10.1016/j.biologicals.2010.01.011. [DOI] [PubMed] [Google Scholar]
  • 51.Enyinda CI, Tolliver D. Taking counterfeits out of the pharmaceutical supply chain in nigeria: Leveraging multilayer mitigation approach. Journal of African Business. 2009;10(2):218–234. doi: 10.1080/15228910903187957. [DOI] [Google Scholar]
  • 52.Musamih, A., Salah, K., Jayaraman, R., Yaqoob, I., Al-Hammadi, Y., Antony, J.: Blockchain-based solution for COVID-19 vaccine waste reduction. J. Clean. Prod. 372, 133619 (2022) [DOI] [PMC free article] [PubMed]
  • 53.Cuadrado, D.C., Hausenkamph, D.S., Aarvik, P., Cardona, C.,  Turati, M., Pardo, N.M.: Safeguarding the covid-19 vaccine distribution: evaluating the role of blockchain. U4 Issue, (2022)
  • 54.Deore AB, Dhumane JR, Wagh R, Sonawane R. The stages of drug discovery and development process. Asian Journal of Pharmaceutical Research and Development. 2019;7(6):62–67. doi: 10.22270/ajprd.v7i6.616. [DOI] [Google Scholar]
  • 55.Schöner MM, Kourouklis D, Sandner P, Gonzalez E, Förster J. Blockchain technology in the pharmaceutical industry. Frankfurt, Germany: Frankfurt School Blockchain Center; 2017. [Google Scholar]
  • 56.Shute R. Blockchain technology in drug discovery: Use-cases in R &D. Curlew Research; 2017. [Google Scholar]
  • 57.Hasan, H.R., Salah, K., Jayaraman, R., Arshad, J., Yaqoob, I., Omar, M.,  Ellahham, S.: Blockchain-based solution for covid-19 digital medical passports and immunity certificates. IEEE Access 8, 222093–222108 (2020) [DOI] [PMC free article] [PubMed]
  • 58.Salah, K., Alfalasi, A., Alfalasi, M., Alharmoudi, M., Alzaabi, M., Alzyeodi, A., Ahmad, R.: IoT-enabled shipping container with environmental monitoring and location tracking. In: IEEE 17th Annual Consumer Communications and Networking Conference (CCNC). pp. 1–6. IEEE (2020)
  • 59.Musamih, A., Jayaraman, R., Salah, K., Hasan, H.R., Yaqoob, I.,  Al-Hammadi, Y.: Blockchain-based solution for distribution and delivery of covid-19 vaccines. IEEE Access, 9, 71372–71387 (2021) [DOI] [PMC free article] [PubMed]
  • 60.Benchoufi M, Ravaud P. Blockchain technology for improving clinical research quality. Trials. 2017;18(1):1–5. doi: 10.1186/s13063-017-2035-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Omar IA, Jayaraman R, Salah K, Yaqoob I, Ellahham S. Applications of blockchain technology in clinical trials: review and open challenges. Arabian Journal for Science and Engineering. 2021;46:3001–3015. doi: 10.1007/s13369-020-04989-3. [DOI] [Google Scholar]
  • 62.Hirano, T., Motohashi, T., Okumura, K., Takajo, K., Kuroki, T., Ichikawa, D., Matsuoka, Y., Ochi, E., Ueno, T.: Data validation and verification using blockchain in a clinical trial for breast cancer: regulatory sandbox. J. Med. Internet Res. 22(6), e18938 (2020) [DOI] [PMC free article] [PubMed]
  • 63.Thorlund K, Dron L, Park J, Hsu G, Forrest JI, Mills EJ. A real-time dashboard of clinical trials for COVID-19. The Lancet Digital Health. 2020;2(6):e286–e287. doi: 10.1016/S2589-7500(20)30086-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Maslove, D.M., Klein, J., Brohman, K., Martin, P.: Using blockchain technology to manage clinical trials data: a proof-of-concept study. JMIR Med. Info 6(4), e11949 (2018) [DOI] [PMC free article] [PubMed]
  • 65.Kumar, A., Krishnamurthi, R., Nayyar, A., Sharma, K., Grover, V., Hossain, E.: A novel smart healthcare design, simulation, and implementation using healthcare 4.0 processes. IEEE Access  8, 118433–118471 (2020)
  • 66.Albanese, G., Calbimonte, J.P., Schumacher, M., Calvaresi, D.: Dynamic consent management for clinical trials via private blockchain technology. J. Ambient Intell. Human. Comput. 2020, pp. 1–18 (2020)
  • 67.Aldred, N., Baal, L., Broda, G., Trumble, S., Mahmoud, Q.H.: Design and implementation of a blockchain-based consent management system. Preprint at http://arxiv.org/abs/1912.09882 (2019)
  • 68.Choudhury, O., Fairoza, N., Sylla, I., Das, A.: A blockchain framework for managing and monitoring data in multi-site clinical trials. Preprint at http://arxiv.org/abs/1902.03975 (2019)
  • 69.Frost SA, Alexandrou E, Schulz L, Aneman A. Interpreting the results of clinical trials, embracing uncertainty: A bayesian approach. Acta Anaesthesiologica Scandinavica. 2021;65(2):146–150. doi: 10.1111/aas.13725. [DOI] [PubMed] [Google Scholar]
  • 70.Abdelazeem, B., Abbas, K.S., Amin, M.A., El-Shahat, N.A., Malik, B., Kalantary, A., Eltobgy, M.: The effectiveness of incentives for research participation: a systematic review and meta-analysis of randomized controlled trials. PloS One 17(4), e0267534 (2022) [DOI] [PMC free article] [PubMed]
  • 71.Albahri O, Albahri A, Mohammed K, Zaidan A, Zaidan B, Hashim M, Salman OH. Systematic review of real-time remote health monitoring system in triage and priority-based sensor technology: Taxonomy, open challenges, motivation and recommendations. Journal of medical systems. 2018;42(5):80. doi: 10.1007/s10916-018-0943-4. [DOI] [PubMed] [Google Scholar]
  • 72.Mohammed K, Zaidan A, Zaidan B, Albahri O, Alsalem M, Albahri A, Hadi A, Hashim M. Real-time remote-health monitoring systems: A review on patients prioritisation for multiple-chronic diseases, taxonomy analysis, concerns and solution procedure. Journal of medical systems. 2019;43(7):223. doi: 10.1007/s10916-019-1362-x. [DOI] [PubMed] [Google Scholar]
  • 73.Suhail C., Samer E.: Telemedicine to revolutionize outpatient based healthcare [Online]. http://thearabhospital.com/articles-eng/telemedicine-revolutionize-outpatient-based-healthcare/ (2020). Accessed on 31 May 2020 (2020)
  • 74.Jeff G.: Telehealth continues to change the face of healthcare delivery—For the better [Online]. https://www.forbes.com/sites/jeffgorke/2019/09/24/telehealth-continues-to-change-the-face-of-healthcare-delivery-for-the-better/#58669cbf565f (2020). Accessed on 27 Apr 2020
  • 75.Vora, J., Nayyar, A., Tanwar, S., Tyagi, S., Kumar, N., Obaidat, M.S., Rodrigues, J.J.: BHEEM: A blockchain-based framework for securing electronic health records. In: IEEE Globecom Workshops (GC Wkshps). pp. 1–6. IEEE (2018)
  • 76.da Conceição, A.F., da Silva, F.S.C., Rocha, V., Locoro, A., Barguil, M.: Eletronic health records using blockchain technology. Preprint at http://arxiv.org/abs/1804.10078 (2018)
  • 77.Jarrett, S., Yang, L., Pagliusi, S.: Roadmap for strengthening the vaccine supply chain in emerging countries: manufacturers’ perspectives. Vaccine vol. 5, (2020) [DOI] [PMC free article] [PubMed]
  • 78.Kumar R., Tripathi, R., (2019) Traceability of counterfeit medicine supply chain through blockchain. In 2019 11th International Conference on Communication Systems & Networks (COMSNETS), pp. 568–570. IEEE (2019)
  • 79.Yang, J.: Three ways china is using drones to fight coronavirus. [Online]. https://www.weforum.org/agenda/2020/03/threeways-china-is-using-drones-to-fight-coronavirus (2020). Accessed on 19 July 2020
  • 80.Zhu, B., Xie, L., Han, D., Meng, X., Teo, R.: A survey on recent progress in control of swarm systems. Sci. Chin. Info. Sci. 60(7), 070201 (2017)
  • 81.Organization WH, et al. Digital tools for COVID-19 contact tracing: Contact tracing in the context of COVID-19. World Health Organization; 2020. [Google Scholar]
  • 82.Ferretti, L., Wymant, C., Kendall, W., Zhao, L., Nurtay, A., Abeler-Dörner, L., Parker, M., Bonsall, D., Fraser, C.: Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science 368, 6491 (2020) [DOI] [PMC free article] [PubMed]
  • 83.Cho, H., Ippolito, D., Yu, Y.W.: Contact tracing mobile Apps for COVID-19: Privacy considerations and related trade-offs. Preprint at http://arxiv.org/abs/2003.11511 (2020)
  • 84.Salathé M, Althaus CL, Neher R, Stringhini S, Hodcroft E, Fellay J, Zwahlen M, Senti G, Battegay M, Wilder-Smith A, et al. COVID-19 epidemic in Switzerland: On the importance of testing, contact tracing and isolation. Swiss Medical Weekly. 2020;150(11–12):w20225. doi: 10.4414/smw.2020.20225. [DOI] [PubMed] [Google Scholar]
  • 85.Reichert L, Brack S, Scheuermann B. Privacy-preserving contact tracing of COVID-19 patients. IACR Cryptol. ePrint Arch. 2020;2020:375. [Google Scholar]
  • 86.Wang, S., Ding, S., Xiong, L.: A new system for surveillance and digital contact tracing for COVID-19: spatiotemporal reporting over network and GPS. JMIR 8(6), e19457 (2020) [DOI] [PMC free article] [PubMed]
  • 87.Arifeen, M.M., Al Mamun, A., Kaiser, M.S., Mahmud, M.: Blockchain-enable contact tracing for preserving user privacy during COVID-19 outbreak. Preprints. 2020070502 (10.20944/preprints202007.0502.v1 (2020)
  • 88.Lv, W., Wu, S., Jiang, C., Cui, Y., Qiu, X., Zhang, Y.: Decentralized blockchain for privacy-preserving large-scale contact tracing. Preprint at http://arxiv.org/abs/2007.00894 (2020) [DOI] [PMC free article] [PubMed]
  • 89.Tang, Q.: Privacy-preserving contact tracing: current solutions and open questions. Preprint at http://arxiv.org/abs/2004.06818 (2020)
  • 90.Chawla A., Ro, S., Coronavirus (COVID-19)–Is blockchain a true savior in this pandemic crisis. Available at SSRN 3655337, (2020)
  • 91.Liu JK, Au MH, Yuen TH, Zuo C, Wang J, Sakzad A, Luo X, Li L. Privacy-preserving covid-19 contact tracing App: A zero-knowledge proof approach. IACR Cryptol. EPrint Arch. 2020;2020:528. [Google Scholar]
  • 92.Hasan, H.R., Salah, K., Jayaraman, R., Yaqoob, I., Omar, M., Ellahham, S.: Covid-19 contact tracing using blockchain. IEEE Access 9, 62956–62971 (2021) [DOI] [PMC free article] [PubMed]
  • 93.Tahir S, Tahir H, Sajjad A, Rajarajan M, Khan F. Privacy-preserving covid-19 contact tracing using blockchain. Journal of Communications and Networks. 2021;23(5):360–373. doi: 10.23919/JCN.2021.000031. [DOI] [Google Scholar]
  • 94.Kumar, R., Khan, A.A., Zhang, S., Wang, W., Abuidris, Y., Amin, W., Kumar, J.: Blockchain-federated-learning and deep learning models for covid-19 detection using ct imaging. Preprint at http://arxiv.org/abs/2007.06537 (2020) [DOI] [PMC free article] [PubMed]
  • 95.Marshall, W.F.: How do COVID-19 antibody tests differ from diagnostic tests? [Online]. https://www.mayoclinic.org/diseases-conditions/coronavirus/expert-answers/covid-antibody-tests/faq-20484429 (2020). Accessed on 8 Aug 2020
  • 96.Eisenstadt M, Ramachandran M, Chowdhury N, Third A, Domingue J. Covid-19 antibody test/vaccination certification: There’s an app for that. Journal of Engineering in Medicine and Biology. 2020;1:148–155. doi: 10.1109/OJEMB.2020.2999214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Bansal A, Garg C, Padappayil RP. Optimizing the implementation of COVID-19 immunity certificates using blockchain. Journal of Medical Systems. 2020;44(9):1–2. doi: 10.1007/s10916-020-01616-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Hicks, C., Butler, D., Maple, C., Crowcroft, J.: Secureabc: Secure antibody certificates for COVID-19. Preprint at http://arxiv.org/abs/2005.11833 (2020)
  • 99.Mohsin, A., Zaidan, A., Zaidan, B., Albahri, O., Albahri, A., Alsalem, M., Mohammed, K.: Blockchain-PSO-AES techniques in finger vein biometrics: a novel verification secure framework for patient authentication. Comput. Stand. Interf. 66, 103343 (2019)
  • 100.Allexandra L.P.: COVID-19 immunity passports and vaccination certificates: Scientific, equitable, and legal challenges [Online]. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31034-5/fulltext (2020). Accessed on 24 Aug 2020 [DOI] [PMC free article] [PubMed]
  • 101.Dai, H.N., Imran, M., Haider, N.: Blockchain-enabled Internet of Medical Things to combat COVID-19. Preprint at http://arxiv.org/abs/2008.09933 (2020)
  • 102.Marios A.C.,  Damianou, A., Katos, V.: DHP framework: Digital health passports using blockchain–Use case on international tourism during the COVID-19 pandemic. arXiv e-prints, pp. 2005, (2020)
  • 103.Alblooshi, M., Salah, K., Alhammadi, Y.: Blockchain-based ownership management for medical IoT (MIoT) devices. In: International Conference on Innovations in Information Technology (IIT). pp. 151–156. IEEE (2018)
  • 104.Simona R.: COVID-19’s impact on data privacy, protection and security [Online]. https://www.episerver.com/guides/covid-19-privacy-considerations (2020). Accessed on 20 July 2020
  • 105.Ienca M, Vayena E. On the responsible use of digital data to tackle the COVID-19 pandemic. Nature Medicine. 2020;26(4):463–464. doi: 10.1038/s41591-020-0832-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Keesara, S., Jonas, A., Schulman, K.: COVID-19 and health care’s digital revolution. N Engl. J. Med. 382(23), e82 (2020) [DOI] [PubMed]
  • 107.Abeler, J., Bäcker, M., Buermeyer, U., Zillessen, H.: COVID-19 contact tracing and data protection can go together. JMIR 8(4), e19359 (2020) [DOI] [PMC free article] [PubMed]
  • 108.Don T.: A new technology to combat the pandemic [Online]. https://thinkers50.com/blog/a-new-technology-to-combat-the-pandemic/ (2020). Accessed on 14 July 2020
  • 109.Faber, B., Michelet, G.C., Weidmann, N., Mukkamala, R.R, Vatrapu, R.: BPDIMS: a blockchain-based personal data and identity management system. Proceedings of the 52nd Hawaii International Conference on System Sciences (2019)
  • 110.Liu, Y., He, D., Obaidat, M.S., Kumar, N., Khan, M.K., Choo, K.K.R., et al.: Blockchain-based identity management systems: a review. J. Netw. Comput. Appl. 2020, 102731 (2020)
  • 111.Lesavre L, Varin P, Mell P, Davidson M, Shook J. A taxonomic approach to understanding emerging blockchain identity management systems. National Institute of Standards and Technology; 2019. [Google Scholar]
  • 112.Cutter, C.M., Nelson, C., Abir, M.: Accountability to population health in the COVID-19 pandemic: designing health care delivery within a social responsibility framework. Population Health Management (2020) [DOI] [PMC free article] [PubMed]
  • 113.Niamh M.: COVID-19: Rapid response in healthcare [Online]. https://www.accenture.com/gben/insights/health/ (2020). Accessed on 22 July 2020
  • 114.Resiere D, Resiere D, Kallel H. Implementation of medical and scientific cooperation in the Caribbean using blockchain technology in coronavirus (COVID-19) pandemics. Journal of Medical Systems. 2020;44:1–2. doi: 10.1007/s10916-020-01589-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Nigel G.: Blockchain’s role in COVID-19 response and recovery [Online]. https://www.ibm.com/blogs/blockchain/2020/04/blockchains-role-in-covid-19-response-and-recovery/ (2020). Accessed on 22 July 2020
  • 116.Sharma, A., Bahl, S., Bagha, A.K., Javaid, M., Shukla, D.K., Haleem, A.: Blockchain technology and its applications to combat covid-19 pandemic. Res. Biomed. Eng. 44, 1–8 (2020)
  • 117.Xi P, Zhang X, Wang L, Liu W, Peng S. A review of blockchain-based secure sharing of healthcare data. Applied Sciences. 2022;12(15):7912. doi: 10.3390/app12157912. [DOI] [Google Scholar]
  • 118.Nizamuddin N, Salah K, Azad MA, Arshad J, Rehman M. Decentralized document version control using ethereum blockchain and ipfs. Computers & Electrical Engineering. 2019;76:183–197. doi: 10.1016/j.compeleceng.2019.03.014. [DOI] [Google Scholar]
  • 119.Pennycook G, McPhetres J, Zhang Y, Lu JG, Rand DG. Fighting COVID-19 misinformation on social media: Experimental evidence for a scalable accuracy-nudge intervention. Psychological science. 2020;31(7):770–780. doi: 10.1177/0956797620939054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Apuke O.D., Omar, B.: Fake news and COVID-19: Modelling the predictors of fake news sharing among social media users. Telematics Info. 2020, 101475 (2020) [DOI] [PMC free article] [PubMed]
  • 121.Elliot S.: Iran minister accuses ‘some countries’ of not declaring their coronavirus cases [Online]. https://www.cnbc.com/2020/03/06/iran-minister-accuses-some-countries-of-not-declaring-coronavirus-cases.html (2020). Accessed on 22 July 2020
  • 122.Fraga-Lamas P, Fernández-Caramés TM. Fake news, disinformation, and deepfakes: Leveraging distributed ledger technologies and blockchain to combat digital deception and counterfeit reality. IT Professional. 2020;22(2):53–59. doi: 10.1109/MITP.2020.2977589. [DOI] [Google Scholar]
  • 123.Fekih R.B., Lahami, M.: Application of blockchain technology in healthcare: a comprehensive study. In: International Conference on Smart Homes and Health Telematics, pp. 268–276. Springer (2020)
  • 124.“Medicalchain,” White Paper, Medicalchain SA, March 2018
  • 125.Raikwar, M., Mazumdar, S., Ruj, S., Gupta, S.S., Chattopadhyay, A., Lam, K.Y.: A blockchain framework for insurance processes. In 9th IFIP International Conference on New Technologies, Mobility and Security (NTMS), pp. 1–4. IEEE (2018)
  • 126.Jayasinghe, D., Cobourne, S.,  Markantonakis, K., Akram, R.N., Mayes, K. (2017) Philanthropy on the blockchain. In: IFIP International Conference on Information Security Theory and Practice, pp. 25–38. Springer (2017)
  • 127.Singh, A., Rajak, R., Mistry, H., Raut, P.: Aid, Charity and donation tracking system using blockchain. In: 2020 4th International Conference on Trends in Electronics and Informatics (ICOEI)(48184), pp. 457–462. IEEE (2020)
  • 128.Ahmed, W., Angel, N., Edson, J., Bibby, K., Bivins, A., O’Brien, J.W., Choi, P.M., Kitajima, M., Simpson, S.L., Li, J., et al.: First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community. Sci. Total Environ. 2020, 138764 (2020) [DOI] [PMC free article] [PubMed]
  • 129.Kumar, M., Patel, A.K., Shah, A.V., Raval, J., Rajpara, N., Joshi, M., Joshi, C.G.: First proof of the capability of wastewater surveillance for COVID-19 in india through detection of genetic material of SARS-CoV-2. Sci. Total Environ. 2020, 141326 (2020) [DOI] [PMC free article] [PubMed]
  • 130.Albahri, O., Zaidan, A., Albahri, A., Zaidan, B., Abdulkareem, K.H., Al-Qaysi, Z., Alamoodi, A., Aleesa, A., Chyad, M., Alesa, R., et al.: Systematic review of artificial intelligence techniques in the detection and classification of covid-19 medical images in terms of evaluation and benchmarking: Taxonomy analysis, challenges, future solutions and methodological aspects. J. Infect. Public Health 2020, 10 (2020) [DOI] [PMC free article] [PubMed]
  • 131.Albahri, A., Hamid, R.A., et al.: Role of biological data mining and machine learning techniques in detecting and diagnosing the novel coronavirus (covid-19): a systematic review. J. Med. Syst. 44, 7 (2020) [DOI] [PMC free article] [PubMed]
  • 132.Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. Jama. 2020;323(16):1582–1589. doi: 10.1001/jama.2020.4783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of the National Academy of Sciences. 2020;117(17):9490–9496. doi: 10.1073/pnas.2004168117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Zafar M, Khan I, Rehman A, Zafar S. A novel blockchain-based model for blood donation system. EAI Endorsed Transactions on Context-aware Systems and Applications. 2022;8(1):e8–e8. doi: 10.4108/eetcasa.v8i1.2546. [DOI] [Google Scholar]
  • 135.Gökalp, E., Gökalp, M.O., Çoban, S., Eren, P.E.: Analysing opportunities and challenges of integrated blockchain technologies in healthcare. In: Eurosymposium on systems analysis and design, pp. 174–183. Springer (2018)
  • 136.Zubaydi HD, Chong Y-W, Ko K, Hanshi SM, Karuppayah S. A review on the role of blockchain technology in the healthcare domain. Electronics. 2019;8(6):679. doi: 10.3390/electronics8060679. [DOI] [Google Scholar]
  • 137.Sullivan F. Global blockchain technology market in the healthcare industry, 2018–2022. Frost Sullivan; 2019. [Google Scholar]
  • 138.“Anonymous epidemic disease testing,” White Paper, Douglas Horn, 2020
  • 139.Charles B.: Telos launches Epios project for anonymous COVID-19 testing [Online]. https://www.enterprisetimes.co.uk/ (2020). Accessed on 02 Aug 2020
  • 140.Chirag B.: 12 Tell-tale signs of blockchain adoption amidst COVID-19 [Online]. https://appinventiv.com/blog/blockchain-adoption-amidst-coronavirus/ (2020). Accessed on 06 Aug 2020
  • 141.Susan M.: MiPasa: An open data platform to support COVID-19 response [Online]. https://mipasa.org/blog/mipasa-an-open-data-platform-to-support-covid-19-response/ (2020). Accessed on 03 Aug 2020
  • 142.Jonathan L., Porter S.: Utilize blockchain-backed COVID-19 data with MiPasa by HACERA [Online]. https://app.mipasa.org/docs/call-for-code-2020# (2020). Accessed on 03 Aug 2020
  • 143.Denise H.: Blockchain and the COVID-19 pandemic: How evolving societal need accelerates emerging technologies [Online]. https://www.himss.org/news/blockchain-coronavirus-emerging-technologies (2020). Accessed on 19 Aug 2020
  • 144.Sam B. G.: VIRI creates global anonymous contact-tracing platform to stop spread of COVID-19 [Online]. https://startupbeat.com/ (2020). Accessed on 18 Aug 2020
  • 145.Jacob C.: VIRI creates global anonymous contact-tracing platform to stop spread of COVID-19 [Online]. https://www.viri.io/ (2020). Accessed on 04 Aug 2020
  • 146.Andy M., Connor S., John B.: Demonstrating 15 contact tracing and other tools built to mitigate the impact of COVID-19 [Online]. https://techcrunch.com/2020/06/05/ (2020). Accessed on 04 Aug 2020
  • 147.Carlos M.,Lena C.: WISeKey’s cutting-edge wise-authentic identity blockchain technology [Online]. https://www.wisekey.com/press/ (2020). Accessed on 04 Aug 2020
  • 148.Carlos M.: Managed PKI services [Online]. https://www.wisekey.com/products-services/digital-identity-pki/trust-services/managed-pki-services/ (2020). Accessed on 04 Aug 2020
  • 149.Carlos M. A.: WISeKey’s WIShelter App now includes a health digital certificate allowing users to share their medical status via a secure QR-CODE [Online]. https://www.newsbreak.com/news/ (2020). Accessed on 04 Aug 2020
  • 150.Vitalik B.: SchellingCoin: a minimal-trust universal data feed. https://blog.ethereum.org/ (2020). Accessed on 02 June 2020
  • 151.“Healpoint,” White Paper, Laboratory Information Systems, Los Angeles, 2018
  • 152.Ahmed E. S.: Spherity contributes to Hackathon for coronavirus solutions [Online]. https://medium.com/spherity/spherity-contributes-to-wirvsvirus-hackathon-for-corona-virus-solutions-3c59b1557fdf. Accessed on 06 Aug 2020
  • 153.Saraf C., Sabadra, S.: Blockchain platforms: a compendium. In: 2018 IEEE International Conference on Innovative Research and Development (ICIRD), pp. 1–6. IEEE (2018)
  • 154.Jill M.: VeChain announces blockchain vaccine tracing solution for China [Online]. https://www.nasdaq.com/articles/vechain-announces-blockchain-vaccine-tracing-solution-china-2018-08-16 (2020). Accessed on 31 Agu 2020
  • 155.Toshendra K. S.: Blockchain use cases to fight COVID-19 [Online]. https://www.blockchain-council.org/blockchain/blockchain-use-cases-to-fight-covid-19/ (2020). Accessed 20 Oct 2020
  • 156.Effective Covid-19 control through carrier tracking and non-pharmaceutical interventions. White Paper, Accubits Technologies, 2020
  • 157.Pascal A.: How do blockchain bridges work? [Online]. https://blog.logrocket.com/blockchain-bridges-cross-chain-data-sharing-guide. (2022) Accessed on 09 Aug 2022
  • 158.Vukolic, M.: On the interoperability of decentralized exposure notification systems. Preprint at https://arvix.org/abs/2006.13087 (2020)
  • 159.Khatoon, A.: Use of blockchain technology to curb novel coronavirus disease (COVID-19) transmission. Available at SSRN 3584226, (2020)
  • 160.Torky, M., Hassanien, A. E.: COVID-19 blockchain framework: innovative approach. Preprint at https://arvix.org/abs/2004.06081 (2020)
  • 161.Huang Y, Bian Y, Li R, Zhao JL, Shi P. Smart contract security: a software lifecycle perspective. IEEE Access. 2019;7:150184–150202. doi: 10.1109/ACCESS.2019.2946988. [DOI] [Google Scholar]
  • 162.Sayeed S, Marco-Gisbert H, Caira T. Smart contract: attacks and protections. IEEE Access. 2020;8:24416–24427. doi: 10.1109/ACCESS.2020.2970495. [DOI] [Google Scholar]
  • 163.Gao Z, Jiang L, Xia X, Lo D, Grundy J. Checking smart contracts with structural code embedding. Trans Softw Eng. 2020;2020:1–10. [Google Scholar]
  • 164.Di Angelo M, Salzer G. International Conference on Decentralized Applications and Infrastructures (DAPPCON) IEEE; 2019. A survey of tools for analyzing Ethereum smart contracts; pp. 69–78. [Google Scholar]
  • 165.Voo TC, Clapham H, Tam CC. Ethical implementation of immunity passports during the COVID-19 pandemic. J Infect Dis. 2020;222(5):715–718. doi: 10.1093/infdis/jiaa352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Ting DSW, Carin L, Dzau V, Wong TY. Digital technology and COVID-19. Medicine. 2020;26(4):459–461. doi: 10.1038/s41591-020-0824-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Wang Z, Jin H, Dai W, Choo KKR, Zou D. Ethereum smart contract security research: survey and future research opportunities. Front Comput Sci. 2021;15(2):1–18. doi: 10.1007/s11704-020-9284-9. [DOI] [Google Scholar]
  • 168.Zhang ST. The Palgrave Handbook of FinTech and Blockchain. Springer; 2021. Bitcoin and other blockchain technologies: mechanisms, governance, and applications; pp. 243–257. [Google Scholar]
  • 169.Muzammal M, Qu Q, Nasrulin B. Renovating blockchain with distributed databases: An open source system. Futur Gener Comput Syst. 2019;90:105–117. doi: 10.1016/j.future.2018.07.042. [DOI] [Google Scholar]
  • 170.Pongnumkul S, Siripanpornchana C, Thajchayapong S. 26th International Conference on Computer Communication and Networks (ICCCN) IEEE; 2017. Performance analysis of private blockchain platforms in varying workloads; pp. 1–6. [Google Scholar]
  • 171.Fuentes L. International Congress on Blockchain and Applications. Springer; 2019. ClinicAppChain: a low-cost blockchain Hyperledger solution for healthcare; p. 36. [Google Scholar]
  • 172.Debe M, Salah K, Rehman MHU, Svetinovic D. IoT public fog nodes reputation system: a decentralized solution using Ethereum blockchain. IEEE Access. 2019;7:178082–178093. doi: 10.1109/ACCESS.2019.2958355. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.


Articles from Cluster Computing are provided here courtesy of Nature Publishing Group

RESOURCES